Plant ID: NPO7591
Plant Latin Name: Cedrus Deodara
Taxonomy Genus: Cedrus
Taxonomy Family: Pinaceae
NCBI TaxonomyDB:
3322
Plant-of-the-World-Online:
n.a.
Ingredient ID: NPC98306
Ingredient ID: NPC88566
Ingredient ID: NPC78551
Ingredient ID: NPC77550
Ingredient ID: NPC76145
Ingredient ID: NPC75844
Ingredient ID: NPC75204
Ingredient ID: NPC75158
Ingredient ID: NPC69581
Ingredient ID: NPC66577
Ingredient ID: NPC64946
Ingredient ID: NPC64849
Ingredient ID: NPC481042
Ingredient ID: NPC481041
Ingredient ID: NPC3649
Ingredient ID: NPC312416
Ingredient ID: NPC309980
Ingredient ID: NPC29976
Ingredient ID: NPC291233
Ingredient ID: NPC290905
Ingredient ID: NPC284183
Ingredient ID: NPC281005
Ingredient ID: NPC273876
Ingredient ID: NPC268862
Ingredient ID: NPC267779
Ingredient ID: NPC26646
Ingredient ID: NPC265961
Ingredient ID: NPC248636
Ingredient ID: NPC241110
Ingredient ID: NPC227378
Ingredient ID: NPC220400
Ingredient ID: NPC217803
Ingredient ID: NPC208553
Ingredient ID: NPC200676
Ingredient ID: NPC194125
Ingredient ID: NPC190810
Ingredient ID: NPC186282
Ingredient ID: NPC181051
Ingredient ID: NPC175569
Ingredient ID: NPC164315
Ingredient ID: NPC16157
Ingredient ID: NPC159398
Ingredient ID: NPC151502
Ingredient ID: NPC144682
Ingredient ID: NPC141777
Ingredient ID: NPC139867
Ingredient ID: NPC115035
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Hydrolase | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Therapeutic Target | Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Therapeutic Target | Methyl-lysine/arginine binding protein | SMN1 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | THRB | Thyroid hormone receptor beta-1 | P10828 | CHEMBL1947 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Protein Kinase | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
Therapeutic Target | Secreted protein | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Drug Transporter | SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Drug Transporter | SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Structural protein | TUBB3 | Tubulin beta-3 chain | Q13509 | CHEMBL2597 |
Therapeutic Target | Unclassified protein | PMP22 | Peripheral myelin protein 22 | Q01453 | CHEMBL1293298 |
Therapeutic Target | Unclassified protein | GMNN | Geminin | O75496 | CHEMBL1293278 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 3306 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT04755543 | A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02270814 | Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03464734 | Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma | urothelial carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00161278 | Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01493505 | EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04611724 | Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients | cancer | Fluorouracil (NPC75844) | NP level |
NCT03990103 | S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002953 | Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00974584 | A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00251355 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00434226 | A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00861627 | Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01277406 | 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00617409 | To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02358031 | A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03907475 | Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, (DURVA+ Study) | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002839 | Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00000758 | A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women | dysplasia of cervix | Fluorouracil (NPC75844) | NP level |
NCT04196283 | Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors | cancer | Paclitaxel (NPC208553) | NP level |
NCT05002686 | Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT03322969 | Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00112489 | Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer | sarcoma | Paclitaxel (NPC208553) | NP level |
NCT05314998 | Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT04854499 | Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002993 | Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus | sarcoma | Mitomycin (NPC139867) | NP level |
NCT05222204 | DDP ip Combined With AG in PDAC With Peritoneal Metastasis | pancreatic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00818090 | Paclitaxel and Cisplatin for Thymic Neoplasm | Thymic Carcinoma;Thymoma | Paclitaxel (NPC208553) | NP level |
NCT02422563 | NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00003877 | Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003018 | S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT04506138 | Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01783197 | Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02038621 | The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00719199 | Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01500993 | Capecitabine in the Perioperative Treatment of Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05268510 | Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib as Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02395705 | Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma | neoplasm of esophagus | Paclitaxel (NPC208553) | NP level |
NCT00043108 | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01929941 | An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies | Hodgkins lymphoma | Paclitaxel (NPC208553) | NP level |
NCT00005078 | Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04077983 | Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholangiocarcinoma | cholangiocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02581501 | Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02122770 | Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00027937 | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT01011010 | Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | liver cancer | Mitomycin (NPC139867) | NP level |
NCT03797443 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02467907 | Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT03740165 | A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT00625573 | Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) | colorectal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00014599 | Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva | vulva cancer | Paclitaxel (NPC208553) | NP level |
NCT01740648 | Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02341456 | Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04278092 | Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00915603 | Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00381706 | Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04390763 | Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00544414 | Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00556088 | LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03175666 | QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01711697 | An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00626782 | Lucentis Versus Mitomycin C During Glaucoma Surgery | glaucoma | Mitomycin (NPC139867) | NP level |
NCT00053911 | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03899636 | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00322452 | First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04604132 | Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00016315 | Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01836029 | Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02132949 | A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04672005 | Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01489566 | Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients | carcinoma | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT00003327 | Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00097227 | Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02355379 | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00047112 | Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04016142 | Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02520154 | Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT00276588 | Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01047007 | A Dose Escalation Study of MK1775 in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05214339 | A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05189483 | Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma. | soft tissue sarcoma | Paclitaxel (NPC208553) | NP level |
NCT00189371 | Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum | anemia (phenotype);ovarian cancer;peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00960960 | A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003992 | Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00289445 | Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) | metastasis | Fluorouracil (NPC75844) | NP level |
NCT05247619 | A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02041533 | An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00793897 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00733408 | Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01205217 | Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBC | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02044601 | Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03043729 | mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00075595 | Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01914900 | Preoperative TPF Chemotherapy in a Population of Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03812783 | HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00809133 | Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002523 | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01888978 | Molecularly Tailored Therapy for Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004126 | Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00003880 | Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00392392 | Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00753909 | Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00347412 | Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00511459 | Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00054210 | Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02322281 | TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01755897 | A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients | cervical adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00929591 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04825938 | Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms | salivary gland neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02302807 | A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00003385 | Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT03852979 | Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00520975 | Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02244502 | Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00626561 | Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02369939 | Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | anal carcinoma | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT01636622 | Study of Vemurafenib, Carboplatin, and Paclitaxel | cancer | Paclitaxel (NPC208553) | NP level |
NCT00002496 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003386 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00652860 | Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery | sarcoma | Mitomycin (NPC139867) | NP level |
NCT00016276 | Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02259621 | Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01179269 | Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00556413 | Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00050167 | Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04216472 | Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04046887 | Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC) | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT03161574 | FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01701349 | Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer | thyroid cancer | Paclitaxel (NPC208553) | NP level |
NCT04150575 | A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT04919226 | Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01084083 | Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT04001829 | Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03003546 | Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial | chronic lymphocytic leukemia | Paclitaxel (NPC208553) | NP level |
NCT02638857 | Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma | hepatocellular carcinoma | Mitomycin (NPC139867) | NP level |
NCT00062062 | Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT04072263 | Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02725268 | A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer | endometrial neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04428151 | Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009) | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05400915 | Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00004160 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03358472 | Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01858883 | Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00737243 | Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site | carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00866528 | Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02256436 | A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045) | urogenital neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02083679 | Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002580 | Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00202774 | Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003298 | Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer | gastric cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03496662 | BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003260 | Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387098 | QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00411138 | Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT02340949 | Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00571740 | Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02474173 | Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00110695 | Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02830139 | Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT05367206 | Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00458315 | Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00016978 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02162719 | Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004) | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02382406 | Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00270790 | EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT01862003 | Phase I/II Trial of Antagonism of HER in GI Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04151277 | PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer | neoplasm | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT02941562 | A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00069901 | Phase II CT-2103/Carboplatin in Ovarian Cancer | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00276796 | Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02741856 | Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT02117024 | A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05446870 | Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02350517 | Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04943653 | Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis | stomach neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03517449 | Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) | endometrial neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02591030 | Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours | bile duct cancer | Fluorouracil (NPC75844) | NP level |
NCT03308552 | Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02 | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03127007 | Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003873 | Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02039674 | A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03344172 | Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05203913 | Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer | urinary bladder carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003957 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT00054054 | S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00087217 | 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00168883 | Study for Patients With Non Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00044785 | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00449137 | Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00505492 | Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy | uterine neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00096668 | Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02358161 | Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03503786 | Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00066274 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03539328 | Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer. | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01374620 | Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel | cancer | Paclitaxel (NPC208553) | NP level |
NCT00806286 | Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02688712 | ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01704703 | Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01024062 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00352105 | Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01367002 | Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00502567 | A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03152370 | Preoperative Radiotherapy and E7046 in Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01009983 | Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03428529 | Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02630823 | MK-3475 Immunotherapy in Endometrial Carcinoma | endometrial carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00734994 | Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer | urinary bladder carcinoma | Mitomycin (NPC139867) | NP level |
NCT00499850 | Phase I FOLFOX Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04859465 | Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma | angiosarcoma | Paclitaxel (NPC208553) | NP level |
NCT04379596 | Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2+ Gastric Cancer (DESTINY-Gastric03) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00006115 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003930 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT03030287 | A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer | Fallopian Tube Carcinoma;ovarian carcinoma;peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00735696 | A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00006786 | Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00088530 | BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) | non-Hodgkins lymphoma | Paclitaxel (NPC208553) | NP level |
NCT04358341 | Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00449657 | Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01570582 | TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02501902 | Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00422682 | A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00041262 | Combination Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04089150 | MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00589238 | Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01750918 | Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT00882973 | Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04949256 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014) | esophageal squamous cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01605344 | Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05485766 | Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer | Hereditary breast and ovarian cancer syndrome | Paclitaxel (NPC208553) | NP level |
NCT00948675 | Study of Participants With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002793 | Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00951665 | A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04370418 | A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab | cancer | Fluorouracil (NPC75844) | NP level |
NCT00004887 | Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | lung cancer | Paclitaxel (NPC208553);Mitomycin (NPC139867) | NP level |
NCT03393884 | A Study of Apatinib Treatment in for Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00254891 | Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01333085 | Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT02352337 | First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00856492 | S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04814485 | Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01121406 | BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00251095 | Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01893294 | Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04832776 | FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00963729 | Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00385021 | ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00189566 | Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse | fallopian tube cancer;ovarian cancer;peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00281658 | ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00723125 | Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00182715 | Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02754726 | Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT03048123 | HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002519 | Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01107665 | Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00655850 | Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00112294 | Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01100931 | A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00955240 | Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02001272 | LDE225 and Paclitaxel in Solid Tumors | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03257033 | Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02376452 | Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02204345 | A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04672928 | A Phase Ib/III Clinical Study to Evaluate the Efficacy and Safety of IBI318 in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel in Patients With Small Cell Lung Cancer Who Have Failed First-line or Above Chemotherapies | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01847677 | Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05312372 | S095033 in Combination With Paclitaxel as 2nd- or 3rd-line Treatment in Participants With Advanced or Metastatic ESCC | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00093795 | Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03057600 | Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC) | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00231582 | High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II | testicular neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02264990 | Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003622 | Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00005838 | Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01827111 | Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT05493332 | HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02732938 | Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT04528680 | Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma | gliosarcoma | Paclitaxel (NPC208553) | NP level |
NCT00003064 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00933426 | Lenalidomide and Paclitaxel in Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT02252796 | Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04594005 | CDK4/6 Tumor, Abemaciclib, Paclitaxel | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04821765 | Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT01218516 | A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00033553 | Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00004897 | Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00181701 | Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02300935 | Study of Trametinib and Nab-paclitaxel in Patients With Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT02272699 | Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00666991 | Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers | peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00465907 | Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT04778839 | Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors. | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00291850 | Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00533949 | High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01822496 | Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01752205 | Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02367794 | A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01376310 | GSK1120212 Rollover Study | cancer | Paclitaxel (NPC208553) | NP level |
NCT03574324 | TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00506779 | Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma | uterine cancer | Paclitaxel (NPC208553) | NP level |
NCT01077739 | A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05449483 | Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00501410 | FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01110603 | A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1) | cancer | Paclitaxel (NPC208553) | NP level |
NCT00322400 | Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04679064 | Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer. | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02365805 | Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01402271 | Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT01653470 | Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens | cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00949182 | Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery | liver cancer | Mitomycin (NPC139867) | NP level |
NCT01200342 | Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT02250599 | Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00003209 | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | cervical cancer | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT00002587 | Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05481645 | Efficacy and Safety of TQB2450 Combined With Chemotherapy ± Anlotinib for Advanced Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT03197571 | QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | urothelial carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | gastrointestinal stromal tumor;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00111007 | A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT04238988 | Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02057380 | A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04958785 | Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03918278 | A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001) | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04634877 | Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) | endometrial neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02923921 | Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00503750 | Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™) | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003596 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT00231075 | Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00070629 | CPG 7909 Injection in Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00609791 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00113516 | A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01127555 | Salvage mFOLFOX in BTC After Failure of Gemcitabine | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00796991 | Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00832299 | Neo-Adjuvant FOLFOX for Rectal Carcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01933061 | Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma | metastatic melanoma | Paclitaxel (NPC208553) | NP level |
NCT04908787 | PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00005644 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function | urethra cancer;urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT04392622 | d-Limonene +Radiation +Platinum Based Chemo for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma | xerostomia | Limonene (NPC76145) | NP level |
NCT04590625 | Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04047862 | Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT05233696 | Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01454180 | Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02959879 | Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00301730 | Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04608409 | Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00006037 | Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00815308 | Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT02640365 | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00346489 | Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C | glaucoma | Mitomycin (NPC139867) | NP level |
NCT02476955 | Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT03997123 | A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02903004 | Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05381909 | Study Investigating BGB-24714 as Monotherapy and in Combination With Chemotherapy in Participants With Advanced or Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00003086 | Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003159 | Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553);Mitomycin (NPC139867) | NP level |
NCT00041470 | Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02440958 | Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01471132 | Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01839773 | A Phase 3 Study to Compare Efficacy and Safety of DHP107 Versus Taxol® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00006015 | Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03780049 | HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01980472 | Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002955 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04390399 | Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00429299 | Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00274456 | Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT05029973 | HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02317419 | Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer | cancer | Paclitaxel (NPC208553) | NP level |
NCT05052931 | Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01470417 | Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00193219 | Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00539331 | Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003888 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01046864 | Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) | cancer | Fluorouracil (NPC75844) | NP level |
NCT03328494 | Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers | cancer | Paclitaxel (NPC208553) | NP level |
NCT00006459 | Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03737643 | An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00855764 | Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00193362 | Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT05135364 | HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02405910 | Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC. | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00559845 | A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01362374 | Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00370760 | Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR) | proliferative vitreoretinopathy | Fluorouracil (NPC75844) | NP level |
NCT02163291 | Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer | gastric carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00574587 | Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01412229 | Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT02069041 | A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01219777 | TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00782041 | Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer | uterine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04188860 | Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy | cervical carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02316171 | CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON) | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00816855 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003001 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00508664 | Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) | hypopharyngeal carcinoma;laryngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02229058 | Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00934895 | Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00030368 | Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03367871 | Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00675259 | Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02581215 | Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01090830 | Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04551950 | Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046) | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00533936 | Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04177108 | A Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer. | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02273713 | The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION) | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03691090 | Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00003956 | Combination Chemotherapy in Treating Patients With Advanced Cancer | lymphoma | Fluorouracil (NPC75844) | NP level |
NCT00008047 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00550784 | Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT04054362 | Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04752696 | Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005825 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | lung cancer | Mitomycin (NPC139867) | NP level |
NCT02047201 | Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04292743 | Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01769508 | Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02730416 | Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT03421353 | AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer | neoplasm | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT03300609 | 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00192049 | A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00083109 | Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer | renal cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01031030 | Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03721744 | A Study of Napabucasin in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00006049 | ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03888677 | Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00580333 | Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01675219 | Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9) | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT04423965 | A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00210184 | Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00028873 | R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04380337 | Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05111860 | Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00416858 | Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00096226 | Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03507491 | A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site | cancer | Paclitaxel (NPC208553) | NP level |
NCT00532285 | Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02508077 | FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01818063 | Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00085163 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00861094 | Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00945191 | A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02070120 | Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00048893 | Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer | metastasis;breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00838656 | First Line Tx Stage III Ovarian Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT03287271 | Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00277043 | A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes | allergic disease | Paclitaxel (NPC208553) | NP level |
NCT00662597 | ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01757288 | Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00025090 | Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer | anus cancer | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT00006472 | Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01661088 | A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00918203 | A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00378716 | Combination Chemotherapy in Treating Patients With Resected Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00539617 | Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03675737 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03197584 | QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy | ovarian cancer | Fluorouracil (NPC75844) | NP level |
NCT01204437 | Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00004206 | Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer | ovarian cancer | Fluorouracil (NPC75844) | NP level |
NCT00198367 | Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00536939 | Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT05493995 | A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. | pancreatic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00370552 | A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT05193604 | A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003893 | Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer | breast cancer | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT02383251 | Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | esophageal carcinoma;stomach neoplasm;adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00508326 | Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement | cancer | Paclitaxel (NPC208553) | NP level |
NCT01641939 | A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT03825328 | A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00143403 | Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer | colorectal neoplasm;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03806049 | Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00145769 | A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03512834 | Paclitaxel-Avelumab for Angiosarcoma | angiosarcoma | Paclitaxel (NPC208553) | NP level |
NCT01338558 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00174707 | Study of Docetaxel in Breast Cancer Patients | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00269828 | A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01204749 | Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00063999 | Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | uterine neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04592861 | Carbon Ion RT for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01843452 | Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal | carcinoma | Mitomycin (NPC139867) | NP level |
NCT02525653 | Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01275677 | Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03830385 | Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01889303 | Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00072553 | Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00954174 | Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer | Fallopian Tube Carcinoma;Uterine Carcinosarcoma | Paclitaxel (NPC208553) | NP level |
NCT01688791 | Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors | cancer | Paclitaxel (NPC208553) | NP level |
NCT00087178 | Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003050 | Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00108745 | Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer | endometrioid carcinoma;undifferentiated carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00988897 | Colorectal Cancer RECHALLENGE | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01310244 | MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02172976 | Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03492047 | N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients | peripheral neuropathy | Paclitaxel (NPC208553) | NP level |
NCT02429700 | TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors | ovarian sex cord-stromal tumor | Paclitaxel (NPC208553) | NP level |
NCT03563144 | QUILT-3.088: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00005021 | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT02597036 | A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00619541 | Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01177956 | A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00287937 | Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01063192 | A Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03727061 | Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer | head and neck carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01276496 | Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04761601 | First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02301143 | Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) | pancreatic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00710736 | A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT03541252 | Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study | basal cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03036488 | Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-173/KEYNOTE-173) | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00404404 | ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00055822 | Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02124707 | Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00226590 | Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02075021 | Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma | multiple myeloma | Paclitaxel (NPC208553) | NP level |
NCT00473720 | Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers | cancer | Paclitaxel (NPC208553) | NP level |
NCT00050960 | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01716949 | Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03468231 | HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02487277 | PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma | adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01827553 | Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02588443 | Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02598687 | Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00004209 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | lung cancer | Mitomycin (NPC139867) | NP level |
NCT00038168 | Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT01099358 | Study in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03435250 | Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT00915005 | Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03941093 | Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00399126 | Phase I Trial of Paclitaxel With Perifosine | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03165994 | APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT03013218 | A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
NCT05132504 | Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04480190 | Neoadjuvant Therapy in Biliary Adenocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04882462 | Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC. | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003087 | Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00618826 | A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02389751 | Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05209074 | Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04602117 | ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer | carcinoid tumor;endometrium neoplasm;gastric cancer;ovarian carcinoma;urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00024141 | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003294 | Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer | leukemia;lymphoma | Paclitaxel (NPC208553) | NP level |
NCT01068132 | Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03189719 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590) | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00729612 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03416153 | Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer | oropharynx cancer | Paclitaxel (NPC208553) | NP level |
NCT03057366 | A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04850235 | Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02730481 | A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00158379 | Taxol Carboplatin and Erythropoetin | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02733250 | Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01357161 | Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00800202 | A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00551759 | Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00513383 | Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck | head and neck squamous cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00129389 | FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02012192 | A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT03908333 | High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00671372 | A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00062010 | Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00102622 | Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03192618 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02861690 | Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05009069 | A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04488159 | Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00753038 | Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00553358 | Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048) | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01993810 | Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00004067 | Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00020449 | Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma | sarcoma | Paclitaxel (NPC208553) | NP level |
NCT03678883 | Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03781323 | Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00730353 | Sutent + Taxol for Advanced Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT04502641 | Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03850769 | Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00583830 | A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00424827 | A Trial of Chemo & Radiation Therapy for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00023660 | Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT01386385 | Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | squamous cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00311636 | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00095914 | Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05253846 | Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02476955 | Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02319018 | Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors | digestive system cancer | Fluorouracil (NPC75844) | NP level |
NCT05092373 | Tumor Treating Fields Therapy in Combination With Chemotherapy for the Treatment of Advanced Solid Tumors Involving the Abdomen or Thorax | renal cell carcinoma;hepatocellular carcinoma;endometrial carcinoma;Fallopian Tube Carcinoma;ovarian carcinoma;breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003042 | Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00646607 | FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00006256 | Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03175939 | Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04289792 | Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer | pancreatic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00625898 | BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00004863 | Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02060253 | Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01372202 | CHFR Methylation Status Esophageal Cancer Study | esophageal cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00002662 | Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02289768 | Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00178256 | Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01245959 | Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00049790 | Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00258323 | Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01718873 | Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02580253 | Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04927780 | Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003350 | Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma | Kaposi's sarcoma | Paclitaxel (NPC208553) | NP level |
NCT01652976 | Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00256243 | Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02043730 | Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer. | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04269200 | Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer | endometrial neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002922 | Paclitaxel in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00016874 | 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05168527 | The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01966471 | A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00081289 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00007878 | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00686114 | Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00118261 | Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00437749 | A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003379 | Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT05024773 | Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) | urinary bladder carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003401 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | multiple myeloma | Paclitaxel (NPC208553) | NP level |
NCT00512096 | Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | penile cancer | Paclitaxel (NPC208553) | NP level |
NCT02193633 | Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel | cancer | Paclitaxel (NPC208553) | NP level |
NCT00478361 | Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function | urethra cancer;urinary bladder carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04267549 | Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Unresectable Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00358163 | Trial of PTK787/ZK 222584 Plus Paclitaxel | cancer | Paclitaxel (NPC208553) | NP level |
NCT04644250 | Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04807673 | Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002) | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00499603 | Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01211210 | Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002937 | Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00002631 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00531687 | Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer | testicular carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002870 | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01383148 | Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02879513 | Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy | inflammatory breast carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00194792 | Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00402545 | C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04607421 | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00632333 | Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01283204 | Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer | gastric cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00993655 | Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | fallopian tube cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00129922 | Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01867892 | A Phase II Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00778102 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004885 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02766582 | Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT05449366 | Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma | malignant peritoneal mesothelioma | Paclitaxel (NPC208553) | NP level |
NCT04094688 | Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02240212 | A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. | cancer | Paclitaxel (NPC208553) | NP level |
NCT00113399 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT04675528 | Food Effect on Pharmacokinetics and SafEty of DHP107 (Liporaxel®) FEEL Study | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00009997 | Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02312804 | Ph Ib/BGJ398/Cervix and Other Solid Tumors | cervical carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00702975 | Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02419495 | Selinexor With Multiple Standard Chemotherapy or Immunotherapy Regimens in Treating Patients With Advanced Malignancies | cutaneous melanoma;Fallopian Tube Carcinoma;metastatic melanoma;ovarian carcinoma;breast carcinoma;non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02937272 | A Study of LY3200882 in Participants With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04711161 | First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers. | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02539537 | A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02311907 | Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer | neuropathy;pain | Paclitaxel (NPC208553) | NP level |
NCT00026130 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03719924 | Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02059499 | Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions | anal neoplasm;squamous cell intraepithelial neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04259944 | Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00646659 | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00004979 | Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002525 | Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04129996 | A Trial of Camrelizumab in Combination With Nab-paclitaxel and Famitinib as a First Line Treatment in Patients With Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer(FUTURE-C-PLUS) | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00006378 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01763671 | Paclitaxel-bevacizumab in Advanced Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01836432 | Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00533936 | Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03879109 | Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00268970 | Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00077129 | Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer | kidney cancer | Paclitaxel (NPC208553) | NP level |
NCT04420884 | A Study of TAK-676 as Single Agent and TAK-676 in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00823186 | Dose-finding Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and Bulky IIA Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00544011 | Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01820754 | Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03393507 | ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00434135 | Alimta and Gemcitabine in Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00717340 | A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01579578 | Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer | cancer | Paclitaxel (NPC208553) | NP level |
NCT03664869 | Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | rectum cancer;colorectal carcinoma;gastrointestinal stromal tumor | Paclitaxel (NPC208553) | NP level |
NCT02000050 | Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01642771 | Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02805257 | Ahmed Glaucoma Valve Surgery With Mitomycin-C | neovascular glaucoma;open-angle glaucoma | Mitomycin (NPC139867) | NP level |
NCT04835896 | Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT02432365 | Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT04781413 | Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT04247126 | A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors | small cell lung carcinoma;pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01288261 | Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01057264 | HAI Abraxane With Gemcitabine and Bevacizumab | cancer | Paclitaxel (NPC208553) | NP level |
NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01649336 | Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02328105 | LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00005046 | Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00003896 | S9912 Combination Chemo in Stage III Ovarian Cancer, | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00603941 | A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel | thyroid cancer | Paclitaxel (NPC208553) | NP level |
NCT04261465 | Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00080951 | Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00259402 | Oxaliplatin in Esophagus Cancer (Advanced) 1st Line | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01075464 | A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors | cancer | Paclitaxel (NPC208553) | NP level |
NCT00075699 | Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma | mesothelioma | Mitomycin (NPC139867) | NP level |
NCT02114359 | Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02434614 | Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03169790 | QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
NCT00851045 | Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05346146 | A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer. | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003322 | Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00039546 | Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03423979 | Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter | benign prostatic hyperplasia | Paclitaxel (NPC208553) | NP level |
NCT00610714 | AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00309543 | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03901118 | Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01332604 | GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT00559455 | Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00052468 | Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01253681 | Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer | carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04766359 | Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00540514 | Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02911350 | Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00005087 | Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT02835586 | STREAMER : STent Restenosis And MEdicaments Release | ischemia | Paclitaxel (NPC208553) | NP level |
NCT02611700 | Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00356811 | Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02607332 | Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib | gastrointestinal stromal tumor | Paclitaxel (NPC208553) | NP level |
NCT00397761 | Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00585052 | A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00542191 | Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03883802 | Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04902261 | Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00731861 | Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors | metastasis;carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02967289 | IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02051751 | A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer | upper aerodigestive tract neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02492503 | Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix | cervical carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00640081 | Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01891357 | Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer | breast ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00209612 | Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT04807140 | Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002) | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00005048 | Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00509964 | Second-Line Irinotecan vs. ILF for AGC | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00077233 | FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00025337 | Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00625092 | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | peritoneum cancer | Fluorouracil (NPC75844) | NP level |
NCT04354961 | Almonertinib Versus Paclitaxel Plus Carboplatin as First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic Pulmonary Adenosquamous Carcinoma (ARISE) | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00768131 | A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01402271 | Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT01779050 | Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02353260 | Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00002888 | Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00334802 | Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00002826 | Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00193193 | Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT01413022 | FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02430311 | The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour. | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02167321 | Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00272987 | Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04478292 | A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT00002593 | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00525915 | Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00052429 | High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05033522 | Immunotherapy for Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01031212 | ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04884906 | Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT04834206 | Nedaplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02975141 | Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01528618 | Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00666237 | Primary Tube Versus Trabeculectomy Study | glaucoma | Mitomycin (NPC139867) | NP level |
NCT00005060 | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00004916 | Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT00749450 | Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03279237 | A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers | esophageal cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03837977 | Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00479856 | Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00544232 | Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00730925 | Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00786110 | Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients | adrenal cortex carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00001442 | A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer | squamous cell carcinoma;upper aerodigestive tract neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03884556 | TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT04862585 | Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel | breast carcinoma in situ | Paclitaxel (NPC208553) | NP level |
NCT00215501 | Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04223024 | Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01137994 | A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04000295 | An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00091377 | Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT01756170 | Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00838656 | Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00460265 | Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00881816 | Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma | gastric carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00654758 | A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02672917 | Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02654119 | Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Patients With Stage I-II HER2/Neu Positive Breast Cancer After Surgery | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002949 | Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | vaginal cancer;cervical cancer;endometrial cancer;urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT03534713 | Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02315196 | Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02382263 | Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00008281 | Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01797900 | The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00003206 | Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT05350943 | HAIC Combined With Toripalimab and Donafenib for Advanced BTC | biliary tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04104672 | A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00280787 | Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03050814 | Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01954355 | Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03167164 | QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy | Merkel cell skin cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00456846 | First Line Therapy for Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03143491 | Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN) | cervical intraepithelial neoplasia | Paclitaxel (NPC208553) | NP level |
NCT03484299 | Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03694002 | Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery | Thymic Carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02506842 | Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT02109341 | Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00507585 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT02050009 | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT03805399 | FUSCC Refractory TNBC Umbrella (FUTURE) | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03519308 | A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Micoenvironment in Resectable Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03086369 | A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01566435 | Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer | upper aerodigestive tract neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03678883 | 9-ING-41 in Patients With Advanced Cancers | Malignant Bone Neoplasm;malignant glioma;kidney cancer;lung neoplasm;metastasis;sarcoma | Paclitaxel (NPC208553) | NP level |
NCT00662311 | Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00005646 | Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00635050 | Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04460066 | A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma. | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT01325441 | A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT00535119 | Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer | Hereditary breast and ovarian cancer syndrome | Paclitaxel (NPC208553) | NP level |
NCT00081302 | Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02676349 | Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00189553 | Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00002894 | Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT03126708 | Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT04060459 | Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT02614534 | Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma | colorectal carcinoma | Mitomycin (NPC139867) | NP level |
NCT00139633 | Selective Dose Escalation for Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00360360 | Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002852 | Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT03577704 | The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. | neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00006004 | Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT04770272 | Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01060007 | Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01572038 | LUX-Breast 2 | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01855828 | Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00046995 | Combination Chemotherapy in Treating Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00231868 | A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma | uterine cancer | Paclitaxel (NPC208553) | NP level |
NCT00476827 | A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02051751 | Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00201435 | Wkly Taxol x 12 | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00021060 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003235 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00154804 | CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT02025023 | Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study | meibomian cyst | Fluorouracil (NPC75844) | NP level |
NCT00433420 | Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04674956 | A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02755311 | Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03192644 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004089 | Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT01787006 | Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00833261 | Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00384878 | Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00719797 | Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00307736 | Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01871571 | Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03000374 | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00021320 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00001569 | Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | peritoneal neoplasm;carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03834948 | AO-176 in Multiple Solid Tumor Malignancies | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04581343 | A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic PC Patients | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00436267 | Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00103974 | Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis | multiple sclerosis | Butylated Hydroxytoluene (NPC144682) | NP level |
NCT00201734 | Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary | adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT05213312 | Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT02779855 | Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer | breast ductal carcinoma in situ | Paclitaxel (NPC208553) | NP level |
NCT00002772 | S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01352689 | CKD-828(80/2.5mg) Pharmacokinetic Study_2nd | hypertension | Paclitaxel (NPC208553) | NP level |
NCT00003078 | Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT00069108 | A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00024388 | Chemotherapy in Treating Patients With Metastatic Kidney Cancer | kidney cancer | Paclitaxel (NPC208553) | NP level |
NCT00787852 | A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03109158 | NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03556839 | Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix | cervical carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003592 | Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT01446458 | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04799639 | Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02303977 | Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02327169 | A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid Tumors | cancer | Paclitaxel (NPC208553) | NP level |
NCT00999973 | Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia | Myopia | Mitomycin (NPC139867) | NP level |
NCT00455533 | Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04703101 | Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00170664 | Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02534337 | Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00024310 | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01763645 | A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00016952 | Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05433597 | A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00006118 | Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03606928 | mFLOT Chemotherapy as First-line Treatment in GC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02739529 | Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer | female reproductive system neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00711243 | Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00838370 | Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002837 | High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00110019 | Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery | cutaneous melanoma | Paclitaxel (NPC208553) | NP level |
NCT02981498 | Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00034541 | Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05358704 | Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00072215 | Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors | testicular neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00960297 | Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00009776 | Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT03866993 | A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer | squamous cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03435289 | A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04164238 | Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients | head and neck squamous cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT02545504 | Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005649 | Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02883062 | Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05262335 | Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001) | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00271011 | A Study of Mitomycin C, Irinotecan, and Cetuximab | colorectal carcinoma | Mitomycin (NPC139867) | NP level |
NCT04632992 | A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | cancer | Paclitaxel (NPC208553) | NP level |
NCT00724386 | Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01121848 | Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01992341 | AMG 386 Drug-Drug Interaction Study With Paclitaxel | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03316599 | Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05476432 | HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04325425 | Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01113476 | Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT02632071 | ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02483104 | Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00079274 | Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00463840 | Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003907 | Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver | liver cancer | Mitomycin (NPC139867) | NP level |
NCT01872403 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01165216 | Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05441254 | Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis:Single-arm, Prospective Clinical Study | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01063517 | Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00563784 | TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01042782 | Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction | gastric cancer | Mitomycin (NPC139867) | NP level |
NCT03396445 | Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00198432 | Chemoradiotherapy of NSCLC Stage IIIB | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002615 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02182232 | A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003013 | Chemotherapy Plus Surgery in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03524508 | Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT03912402 | Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA) | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT05217069 | A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00065117 | Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
NCT05283226 | Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00113438 | Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors | cancer | Paclitaxel (NPC208553) | NP level |
NCT02008656 | Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01534585 | Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00289445 | Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) | neoplasm | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT01220154 | Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel Bevacizumab for Primary Ovarian | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03029611 | Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04937673 | The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00645177 | Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00073723 | Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01503372 | FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03697239 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00865189 | A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00008138 | S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00002628 | Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04839731 | Combination 5-FU / Calcipotriene Cream for SCCIS/SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00481078 | Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003251 | Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00423293 | Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | anus cancer | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT00889343 | Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00655876 | Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00691379 | Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00377273 | An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00680758 | Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00615056 | A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00117572 | Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) | laryngeal neoplasm;oral cavity cancer;paranasal sinus neoplasm;pharynx cancer | Fluorouracil (NPC75844) | NP level |
NCT01721746 | A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) | metastatic melanoma | Paclitaxel (NPC208553) | NP level |
NCT04282070 | SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01802645 | Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02842580 | De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00010257 | Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma | Thymic Carcinoma;Thymoma | Paclitaxel (NPC208553) | NP level |
NCT01146795 | Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02246049 | A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00613080 | Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00154726 | Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT02967887 | Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02648425 | Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00055601 | Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03641183 | Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02124148 | A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
NCT02885753 | Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02897700 | A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00193310 | Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01236716 | Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00004092 | Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03910634 | IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02016898 | The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device | open-angle glaucoma | Mitomycin (NPC139867) | NP level |
NCT00525785 | Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00146549 | Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03812770 | Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05108428 | Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00111904 | Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04037072 | Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures | Esophageal stenosis | Mitomycin (NPC139867) | NP level |
NCT00551733 | Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT04826679 | Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00005831 | Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer | urinary bladder carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00193141 | Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT05054439 | A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00426556 | Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00005586 | Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003172 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01536223 | Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00016900 | PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00881166 | Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors | cancer | Paclitaxel (NPC208553) | NP level |
NCT00124943 | Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis | Coronary Restenosis | Paclitaxel (NPC208553) | NP level |
NCT02366143 | A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03154294 | Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00522834 | Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT04888403 | Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00028743 | Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00500292 | A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT01730833 | Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03329248 | QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01136031 | Paclitaxel and Irinotecan in Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00629278 | Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01036087 | Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00647530 | Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004125 | Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04371224 | NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00491855 | Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00104676 | Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors | teratoma;testicular neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00930930 | Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03636308 | Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02033538 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01507428 | Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003446 | Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003214 | Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03181100 | Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer | thyroid carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02897050 | Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02379416 | Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02697838 | Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | large cell lung carcinoma;squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00520000 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00825201 | A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00507429 | Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer | thyroid cancer | Paclitaxel (NPC208553) | NP level |
NCT03658304 | Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma | urothelial carcinoma | Mitomycin (NPC139867) | NP level |
NCT00147537 | Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003539 | Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01748851 | XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01083537 | Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer | fallopian tube cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT01650376 | Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer | uterine cancer | Paclitaxel (NPC208553) | NP level |
NCT00268398 | Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003589 | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00807911 | Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03760614 | A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00665392 | Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00416507 | Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00001428 | A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003326 | Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT02506803 | Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer. | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05081609 | A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response | cancer | Paclitaxel (NPC208553) | NP level |
NCT02717091 | Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00006929 | Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00526110 | Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | gastrointestinal disease | Fluorouracil (NPC75844) | NP level |
NCT02607982 | CCRT for Esophageal Cancer. | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT03771846 | HAIC Versus Systemic Chemotherapy for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04793932 | Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003254 | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00318136 | A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05420636 | Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00483301 | A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT04431258 | ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01472016 | Study of ABT-700 in Subjects With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01594099 | Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02311101 | Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | bladder tumor | Mitomycin (NPC139867) | NP level |
NCT00003576 | Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00393068 | Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT03785873 | Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT01286766 | Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01666418 | Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00642577 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00490711 | Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT05319730 | A Study to Evaluate Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01647828 | A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02020707 | Abraxane/Bevacizumab | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT01279291 | Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer | Fallopian Tube Carcinoma;ovarian neoplasm;peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03537690 | FID-007 in Treating Participants With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00997906 | Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT02218164 | Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma | skin carcinoma;squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01506973 | A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer | adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT04056949 | Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00032032 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02217020 | Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01934634 | Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02244632 | Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01555853 | Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma | Hodgkins lymphoma;non-Hodgkins lymphoma | Paclitaxel (NPC208553) | NP level |
NCT00952029 | Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01358877 | A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00976677 | Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00459121 | Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00002579 | Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01968915 | Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02776917 | Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00014118 | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00900627 | Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00038545 | A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Paclitaxel (NPC208553) | NP level |
NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | laryngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04303429 | Adjuvant Chemotherapy in High Risk Stage II Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02769832 | Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00879359 | Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer | endometrial carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03871036 | Improve Checkpoint-blockade Response in Advanced Urothelial Cancer | urothelial carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00323011 | FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03815461 | Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003642 | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT02735239 | Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer | esophageal cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006110 | Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00005068 | Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05253651 | A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01004978 | Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | hepatocellular carcinoma | Mitomycin (NPC139867) | NP level |
NCT00031876 | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00403130 | Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00005051 | Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02033993 | Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen. | urogenital neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02220673 | Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B) | asthma | Butylated Hydroxytoluene (NPC144682) | NP level |
NCT02570893 | A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT04962958 | Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006469 | Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01302613 | Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01024712 | Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT04354662 | Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003397 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT04767295 | A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC) | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00762034 | A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01457846 | Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01641783 | Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00954512 | Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) | neoplasm | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00295789 | Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3) | cervical adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00546156 | Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03087864 | PDL-1 Targeting in Resectable Oesophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT01268059 | A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05459129 | A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer) | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00379262 | Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002747 | Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03600623 | Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01192165 | Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel | cancer | Paclitaxel (NPC208553) | NP level |
NCT00445458 | A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00203905 | A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00527111 | Pre-op Rectal ChemoRad +/- Cetuximab | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00295893 | Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00039208 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
NCT00002774 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02272738 | A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01821859 | A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00046423 | A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies | metastasis;neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04895358 | Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00755118 | Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00773695 | A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04723030 | The Transformation of Locally Advanced Pancreatic Cancer. | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01015339 | Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00518284 | Prevention of Restenosis Following Revascularization | peripheral vascular disease | Paclitaxel (NPC208553) | NP level |
NCT00061646 | Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03058757 | The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00003230 | Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia | leukemia | Paclitaxel (NPC208553) | NP level |
NCT04527900 | The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00831181 | Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04943445 | Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers | laryngeal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00174434 | Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05290935 | Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial | cervical carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00001569 | Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | peritoneal neoplasm;carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02121990 | Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03946969 | Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00507091 | Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003591 | Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02979392 | Phase I Study of TENPA in Advanced Solid Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00004057 | Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT02625623 | Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02281682 | IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00003399 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | multiple myeloma | Paclitaxel (NPC208553) | NP level |
NCT01196741 | Neoadjuvant Therapy for Ovarian Cancer | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00088114 | STA-4783 and Paclitaxel for Treatment of Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05025033 | Chemotherapy Combined With Apatinib and PD-1 Antibody | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT02777437 | Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02513563 | AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01258192 | Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002717 | Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00003696 | Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02440425 | A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00198354 | Stage I/II NSCLC Perioperative Chemotherapy | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00567554 | Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003117 | Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01187199 | Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer | cancer | Paclitaxel (NPC208553) | NP level |
NCT00003664 | Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT05074966 | The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04718415 | Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma | oral squamous cell carcinoma;oropharynx squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02461043 | Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT02595554 | Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer | cervical carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00958737 | Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04808687 | Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer | pancreatic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05190445 | Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ Andenocarinoma | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00382629 | BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis | relapsing-remitting multiple sclerosis | Butylated Hydroxytoluene (NPC144682) | NP level |
NCT00193206 | Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00468169 | Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03605706 | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02876302 | Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03515798 | Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01442935 | Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01314833 | Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02402842 | Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma | anal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03940001 | A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01485744 | LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00024401 | DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00286000 | High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00004159 | Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01688700 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00735345 | Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00006103 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00993655 | AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03853707 | Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04339738 | Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma | angiosarcoma | Paclitaxel (NPC208553) | NP level |
NCT02987699 | Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02486601 | NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma | stomach neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00851877 | Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00003111 | Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00160030 | Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00015886 | Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01992705 | Borderline Pancreas Study: FOLFIRINOX +SBRT | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00454649 | Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00004265 | Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03042780 | FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas | pancreatic endocrine carcinoma;pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01688024 | Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis | sclerosing cholangitis | Mitomycin (NPC139867) | NP level |
NCT00020917 | Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01281176 | High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00191854 | Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01461915 | Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03800693 | 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers | digestive system cancer | Fluorouracil (NPC75844) | NP level |
NCT00629278 | Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00614484 | Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02308553 | Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma | cutaneous melanoma | Paclitaxel (NPC208553) | NP level |
NCT00002897 | Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01608464 | Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006454 | Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03801668 | Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT04938583 | A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00434356 | A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B) | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03554109 | QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02742051 | A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04418895 | Neoadjuvant Therapy for Localized Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04063683 | Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma(ESCC). | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003118 | Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT05042128 | The ASCEND Study: Gemcitabine and Nab-Paclitaxel With CEND-1 or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT04481204 | New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03498521 | Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT00652119 | Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01285609 | Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00750386 | An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01442519 | Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT01057342 | Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01239732 | Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00020488 | Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04625543 | Neoadjuvant Immunotherapy to ESCC | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02092363 | GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00480831 | A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00090025 | XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT05158062 | Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05201547 | Endometrial Cancer Patientes MMR Deficient Comparing Chimiotherapy vs Dostarlimab in First Line | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT01086826 | Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05214976 | A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00404235 | Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | cutaneous melanoma | Paclitaxel (NPC208553) | NP level |
NCT00027833 | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01248403 | A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT04999969 | Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01270373 | NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00980460 | Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT05254171 | Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00772798 | Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03943043 | Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer | cholangiocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02644863 | Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00261703 | Docetaxel in Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02514031 | ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00608205 | Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00980954 | Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00003627 | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05125055 | Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC | oral squamous cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00584857 | A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer | uterine cancer | Paclitaxel (NPC208553) | NP level |
NCT00479583 | Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX | cancer | Fluorouracil (NPC75844) | NP level |
NCT03970252 | Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04634539 | Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00553462 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03932409 | Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT01627379 | Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01649336 | A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT00513786 | Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00262808 | GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04437329 | Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05472259 | A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02106884 | Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01199055 | CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05316376 | MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients. | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00009828 | Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01138046 | A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01225302 | A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04296175 | Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE) | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01364012 | A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02212015 | Evaluation of Votrient in Angiosarcoma | angiosarcoma | Paclitaxel (NPC208553) | NP level |
NCT01711970 | SGI-110 in Combination With Carboplatin in Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00005065 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00094835 | Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00454324 | Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002711 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT01269229 | A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00350025 | Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00194779 | Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00795899 | Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00984464 | Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma | metastatic melanoma | Paclitaxel (NPC208553) | NP level |
NCT01174238 | A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00005819 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03520790 | Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02494583 | Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01034189 | Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT03412799 | Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003175 | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT05298020 | Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02715804 | A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01171170 | Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03432598 | Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00005849 | Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01821859 | Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01834235 | QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02762474 | Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00653952 | CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00442260 | Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003972 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04005170 | Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00002928 | Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03524898 | NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma | soft tissue sarcoma | Paclitaxel (NPC208553) | NP level |
NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00817583 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01523457 | Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04516616 | Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer | cervical adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00967291 | Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Mitomycin (NPC139867) | NP level |
NCT00005032 | Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00979212 | Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03921684 | Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02641691 | Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01226719 | FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00101894 | Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00088556 | Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03693612 | GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00183885 | A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma | hepatocellular carcinoma | Mitomycin (NPC139867) | NP level |
NCT04865289 | Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study | endometrial neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02157870 | Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02995772 | Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00462397 | Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02551991 | Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00126256 | Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma;metastasis | Fluorouracil (NPC75844) | NP level |
NCT01150045 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00324415 | Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT02588105 | Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01836653 | Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00025480 | Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00937560 | ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01572324 | Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00499525 | Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03748134 | Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02359968 | PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05189730 | Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00677118 | Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00976911 | Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03649321 | Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05455918 | Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor | childhood germ cell tumor | Paclitaxel (NPC208553) | NP level |
NCT00482391 | Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00449098 | Ologen (OculusGen)-Glaucoma MMC Control Trial in India | glaucoma | Mitomycin (NPC139867) | NP level |
NCT00193284 | Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04908566 | Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01234038 | Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04579224 | Comparing the New Anti-cancer Drug Eribulin With or Without Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer | urethra cancer | Paclitaxel (NPC208553) | NP level |
NCT01479465 | Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00028769 | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT03056833 | Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer | peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01652482 | Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02109445 | Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03292822 | Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00278148 | Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00887575 | Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04046575 | Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02744898 | A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT04510064 | PD-1 Antibody Combined With Modified FLOT Regimen in the Treatment of Unresectable Locally Advanced or Limited Metastatic Gastric Cancer | gastric adenocarcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT02695771 | The Bladder Instillation Comparison Study | bladder tumor | Mitomycin (NPC139867) | NP level |
NCT00004099 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00707707 | Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03503604 | A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT04009876 | A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02985333 | Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma | multiple myeloma | Paclitaxel (NPC208553) | NP level |
NCT01953445 | A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02020707 | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers | cervical adenocarcinoma;cutaneous melanoma | Paclitaxel (NPC208553) | NP level |
NCT00001272 | A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02451956 | Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT03322566 | A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06) | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00251472 | A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04149015 | Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT02993731 | A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002819 | Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02064491 | Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02276560 | Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00246103 | Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04974944 | First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT01702714 | A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00191672 | A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05022030 | First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01493310 | Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03197584 | Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00864253 | A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00915018 | Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00986674 | Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003193 | Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT03579784 | Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02013453 | A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT02723955 | Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) | neoplasm | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00773695 | A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00087802 | Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03219762 | Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03336216 | A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT05462496 | Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00301028 | Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004097 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00006257 | SU5416 and Paclitaxel in Treating Patients With Advanced Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05257993 | Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00989651 | Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | endometrioid carcinoma;undifferentiated carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03574649 | QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00080418 | Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03807999 | Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer | pancreatic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02715531 | A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors | neoplasm | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00084448 | Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00002939 | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02713386 | Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | endometrioid carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04324307 | Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02639650 | Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor | gestational trophoblastic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04314895 | Trial of NanoPac Intratumoral Injection in Lung Cancer | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01802749 | Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00009737 | A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004865 | Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy | head and neck malignant neoplasia | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00042835 | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | lung adenocarcinoma;squamous cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04138719 | Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00085839 | Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03517176 | CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01578551 | Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT05179239 | A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00971867 | Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT04225364 | Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01822756 | An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00702572 | Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00001384 | A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02186847 | Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer | bronchoalveolar adenocarcinoma;large cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00049348 | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02243007 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT02625610 | Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01985724 | Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00971841 | Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT01622543 | Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00547443 | Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02115204 | 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04649476 | Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00262951 | Chemoradiation in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00043121 | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00886717 | Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03975270 | Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma ) | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00009932 | Combination Chemotherapy in Treating Patients With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00413322 | Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02741570 | Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00193011 | Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04172675 | A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) | bladder tumor | Mitomycin (NPC139867) | NP level |
NCT00193596 | Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02916511 | Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00479765 | A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma | brain neoplasm;glioblastoma multiforme | Paclitaxel (NPC208553) | NP level |
NCT00011921 | Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00555672 | Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00388700 | A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01146795 | Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT02459457 | A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer | squamous cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01224652 | Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00025688 | Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01980810 | First Line Chemotherapy for Advanced Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00009802 | Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04581265 | Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor. | germ cell tumor | Paclitaxel (NPC208553) | NP level |
NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02453282 | Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01198548 | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00055887 | Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01822613 | Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC) | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01133990 | FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02483247 | A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT02017015 | Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer | pancreatic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002632 | Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT01815359 | ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis | appendix cancer;colorectal carcinoma | Mitomycin (NPC139867) | NP level |
NCT00259675 | Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00816634 | Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00199758 | Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02059967 | Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC | lung adenocarcinoma;squamous cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00140140 | A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02817113 | Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | gastric cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01417494 | 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02583477 | Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02845908 | POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC | gastric cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03892018 | The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00289445 | Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) | metastasis | Mitomycin (NPC139867) | NP level |
NCT00789581 | A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00603538 | Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00943137 | The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT02994251 | A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma | cholangiocarcinoma | Mitomycin (NPC139867) | NP level |
NCT00352755 | A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis | peritoneal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00317200 | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00517621 | Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire | fallopian tube cancer;ovarian cancer;peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01347645 | Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03723967 | FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02272790 | Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT02926183 | Study of NAC of GA Therapy for Patients With BRPC | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00155883 | Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02142738 | Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00268372 | S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01730222 | A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00031577 | Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | Central Nervous System Neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03884101 | Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) | endometrial neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002582 | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00983541 | Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma | cancer | Fluorouracil (NPC75844) | NP level |
NCT00287989 | Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01494363 | Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00425152 | Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002542 | Tamoxifen in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00832494 | Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00448136 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00022178 | Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005647 | SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00003577 | Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Fluorouracil (NPC75844) | NP level |
NCT01525602 | Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00933387 | A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma | mouth neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03197935 | A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03278626 | Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00103103 | Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01621243 | M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05192798 | Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03430843 | A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003862 | Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | gastric cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00188877 | Intensity Modulated Radiation Therapy for Head and Neck Cancer | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01770171 | Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00861705 | Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05171530 | Lenvatinib With Taxane Drugs Treatment for Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT02038647 | Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00387387 | Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006094 | Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01039844 | Study of Weekly LOC-paclitaxel Injection for Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00003008 | Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma | sarcoma | Paclitaxel (NPC208553) | NP level |
NCT02307487 | Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00716534 | Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01963325 | S-1 in Combination With Abraxane in Treating Cholangiocarcinoma | cholangiocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02948543 | Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT04581876 | The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02481635 | A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02251951 | Study of Afuresertib Combined With Paclitaxel in Gastric Cancer | cancer | Paclitaxel (NPC208553) | NP level |
NCT00388076 | A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03725436 | ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003049 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00680940 | A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01006252 | A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT03345810 | Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) | large cell lung carcinoma;lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01694576 | NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01858025 | Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma | carcinoma | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT05410847 | Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT02220894 | Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05360732 | Redefining FOLFIORINOX in Older Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04004871 | Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01183663 | Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) | cancer | Fluorouracil (NPC75844) | NP level |
NCT00453167 | Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01712919 | Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00797485 | Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04729608 | Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00367471 | Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02385370 | Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method | glaucoma | Mitomycin (NPC139867) | NP level |
NCT02689427 | Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00033696 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01081951 | Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03368859 | A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin | cancer | Fluorouracil (NPC75844) | NP level |
NCT02774187 | Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003013 | Chemotherapy Plus Surgery in Treating Women With Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00499369 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03586869 | QUILT-3.080: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03641976 | A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04027764 | Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer | biliary tract cancer | Paclitaxel (NPC208553) | NP level |
NCT04426955 | Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00747799 | Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01839487 | PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04190745 | Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT04077255 | EGFR-targeted Therapy for Gastric Cancer | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00807859 | Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003394 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00723957 | A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01244789 | Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01836679 | Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00940303 | OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03894540 | Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00454116 | A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005581 | Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | esophageal cancer;gastric cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00001450 | Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03348904 | Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03764553 | Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04931342 | Chiauranib Plus Weekly Paclitaxel in Patients With Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00062426 | Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01405235 | Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT01246193 | CKD-828(80/2.5mg) Pharmacokinetic Study | hypertension | Paclitaxel (NPC208553) | NP level |
NCT00343291 | A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00558636 | A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00786006 | Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02221999 | Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02017600 | A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05322499 | Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00042887 | Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00111787 | Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03126812 | Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC). | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00321685 | Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00077220 | Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03872791 | A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00373620 | A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00053820 | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT04729387 | Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01591135 | A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT02684227 | Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer | uterine neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00011986 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02279134 | Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01821729 | Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02391662 | Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04647344 | A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03487939 | Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02545010 | Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00262847 | Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | endometrioid carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01804790 | Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04374630 | Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01042379 | I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer | angiosarcoma;triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03387592 | CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04705519 | Nab-paclitaxel Combined With Bevacizumab in the Treatment of Metastatic Neuroendocrine Carcinoma | neuroendocrine carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02426450 | RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004150 | High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00526890 | Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00607438 | A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00084214 | STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00008021 | Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT05174156 | Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT04084496 | mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02181634 | Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma | cholangiocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01435018 | Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS | HIV-1 infection | Paclitaxel (NPC208553) | NP level |
NCT02393833 | IBCSG Trial 22-00 Serum Substudy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00004257 | Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00031954 | Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT01220128 | Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04475016 | TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer | penile cancer | Paclitaxel (NPC208553) | NP level |
NCT01621217 | Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 | anal neoplasm | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT00004252 | Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01905150 | Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | pancreatic carcinoma | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT01880385 | Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer | inflammatory breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00024375 | DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00401674 | MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00777673 | Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery. | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00070213 | Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00030654 | Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT02590133 | A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02448329 | Study of AZD1775 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring TP53 Mutation as a Second-line Chemotherapy | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01312350 | Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01704287 | Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002) | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00334321 | Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT02593708 | Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+ | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01166542 | Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00964626 | Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00228319 | Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01431794 | Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00148395 | Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. | non-small cell lung carcinoma | Mitomycin (NPC139867) | NP level |
NCT05427383 | KN026 in Combination With Chemotherapy in the Second Line Treatment of HER-2 Positive Advanced or Metastatic Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00012311 | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00004174 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01197664 | Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03417921 | A Study of ABTL0812 in Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01263834 | Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome | glaucoma | Mitomycin (NPC139867) | NP level |
NCT04856137 | A Phase I/II Study of Diffuse Large B-cell Lymphoma | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT00006484 | Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00138151 | Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT03977220 | Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage Ⅲ Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT02241551 | Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01496742 | A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04714190 | A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression | gastric carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00832819 | E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00578149 | Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00004094 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx | head and neck malignant neoplasia | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03818282 | Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01558492 | Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT05070598 | Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00154882 | Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03281369 | A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) | esophageal carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT04563975 | Efficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01481545 | Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00035152 | Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01303497 | Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas | angiosarcoma | Paclitaxel (NPC208553) | NP level |
NCT01297452 | BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02810418 | Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors | pancreatic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00005791 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02199418 | Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03694522 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05171166 | Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03085992 | Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04888663 | Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study) | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00296322 | Trial of Adjuvant Chemotherapy for Gastric Cancer | gastric cancer | Mitomycin (NPC139867) | NP level |
NCT00046514 | ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer | metastasis;breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04182724 | Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00873119 | Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary | carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01515306 | A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00006018 | Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03428425 | A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT03671252 | Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03959293 | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387111 | QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed | squamous cell carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT04213898 | SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01937507 | Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | chronic myeloproliferative disorder;multiple myeloma;myelodysplastic syndrome | Fluorouracil (NPC75844) | NP level |
NCT00002581 | Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02426281 | Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT04006041 | Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00042861 | UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00893490 | Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma | glaucoma | Mitomycin (NPC139867) | NP level |
NCT00936702 | Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary | carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04209686 | Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00016133 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03025477 | Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02030990 | The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements | Corneal opacity | Mitomycin (NPC139867) | NP level |
NCT03026881 | A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT04215731 | Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02437812 | Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02207465 | A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01843829 | A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00119262 | Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05491694 | To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00047099 | Combination Chemotherapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04336098 | Study of SRF617 in Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02711137 | Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002854 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer | cancer | Paclitaxel (NPC208553) | NP level |
NCT00770809 | Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00308516 | 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00394082 | ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00100789 | S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT01590719 | A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002679 | Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00055133 | A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis | rheumatoid arthritis | Paclitaxel (NPC208553) | NP level |
NCT04589234 | Saltikva for Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT03486314 | A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02450058 | Adjuvant FEC Versus EP in Breast Cancer (MIG5) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00398086 | Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00373256 | Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer. | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00313768 | Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003637 | Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003029 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02187991 | Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00191256 | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04804696 | Toripalimab With Paclitaxel and Cisplatin as Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03544567 | A Study of Oraxol in Subjects With Cutaneous Angiosarcoma | angiosarcoma | Paclitaxel (NPC208553) | NP level |
NCT03101748 | Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02307227 | A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03169777 | QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC | colorectal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01217060 | Trimodality Management of T1b Esophageal Cancers | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03742102 | 9-ING-41 in Patients With Advanced Cancers | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04447092 | Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003128 | Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus | sarcoma | Paclitaxel (NPC208553) | NP level |
NCT00111761 | Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00629499 | Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00107094 | Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00052910 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00220649 | Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04568200 | Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02384850 | Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02048943 | Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00702299 | Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00217607 | Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery | sarcoma | Paclitaxel (NPC208553) | NP level |
NCT01946074 | A Study of ABT-165 in Subjects With Solid Tumors | neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00017407 | Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02762981 | Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00016406 | S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02834975 | Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT04393298 | A Study to Assess the Safety, Pharmacokinetics and Antitumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00025298 | Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT02019355 | Actinic Keratosis Study | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT01953406 | The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma | hepatocellular carcinoma | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT03484221 | Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04031703 | Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01042041 | Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer | hepatocellular carcinoma | Mitomycin (NPC139867) | NP level |
NCT01088815 | Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01696032 | Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00166465 | Stage IV Colorectal CA ALIMTA | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01591733 | FOLFIRINOX + RT for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04539808 | NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00983424 | Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00407888 | Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04492033 | A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients | biliary tract cancer | Paclitaxel (NPC208553) | NP level |
NCT01530503 | Second Line Therapy in Advanced Biliary Tract Cancer | biliary tract cancer | Mitomycin (NPC139867) | NP level |
NCT03013218 | A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) | non-Hodgkins lymphoma | Paclitaxel (NPC208553) | NP level |
NCT03944304 | Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib. | gastrointestinal stromal tumor | Paclitaxel (NPC208553) | NP level |
NCT00274937 | Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02246127 | Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced Pancreatic Neuroendocrine Tumor (pNET) | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03881111 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02881125 | Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma | small cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003943 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. | lung cancer;carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05078827 | Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00003012 | Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00004164 | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00006012 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00004924 | Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01519804 | A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00146562 | Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01820858 | The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma | endometrial neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01013805 | Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00321828 | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002696 | Combination Chemotherapy in Treating Women With Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00499083 | Paclitaxel, Cyclophosphamide, and Doxorubicin Followed by Autologous Dendritic Cells and Surgery With or Without Radiation Therapy and/or Hormone Therapy in Treating Women With Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04838496 | Induction Chemotherapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003944 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00447967 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00997009 | Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00378313 | A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01289821 | First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04815408 | Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00601627 | Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00021398 | Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01852292 | Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01238133 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00559845 | A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05329766 | A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT04148885 | A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00919880 | Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00919984 | Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01676259 | A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02050009 | GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT02921256 | Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04342910 | Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00000122 | Fluorouracil Filtering Surgery Study (FFSS) | glaucoma | Fluorouracil (NPC75844) | NP level |
NCT00148681 | Preoperative Herceptin and Navelbine for Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02072317 | Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT04594772 | Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01529164 | Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02794571 | Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00373217 | Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00193531 | Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma | neuroendocrine carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05235542 | A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or Chemotherapy or TransCon TLR7/8 Agonist in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT01893801 | Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04134468 | MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00728845 | Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00041119 | Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00004059 | Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02593175 | Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00511849 | Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01047293 | RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02024607 | BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) | cancer | Fluorouracil (NPC75844) | NP level |
NCT01009515 | Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00276744 | Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Mitomycin (NPC139867) | NP level |
NCT02317991 | Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT01676649 | Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT04004234 | A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC | biliary tract cancer | Paclitaxel (NPC208553) | NP level |
NCT00872625 | Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03069950 | Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02135822 | Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00296335 | Trial of Adjuvant Chemotherapy for Gastric Cancer | gastric cancer | Mitomycin (NPC139867) | NP level |
NCT00427310 | Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00340184 | A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00486954 | Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01774786 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03883919 | Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00661583 | Use of Ranibizumab With Mitomycin C During Trabeculectomy | glaucoma | Mitomycin (NPC139867) | NP level |
NCT01444547 | A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT02107378 | Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01238965 | Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00705016 | Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05204173 | Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT05489848 | Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT02640755 | Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer | cancer | Paclitaxel (NPC208553) | NP level |
NCT00697905 | Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03731442 | Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00201396 | A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT00314678 | Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02366949 | A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT00063401 | Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer | Fallopian Tube Carcinoma;ovarian cancer;peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01838538 | Abraxane/Bevacizumab | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT05466799 | FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01633970 | A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00136539 | Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03020329 | Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT04143711 | Study of DF1001 in Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03585062 | Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04982237 | A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT04961970 | HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01107626 | Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00093665 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03083470 | Study of SOR007 Ointment for Actinic Keratosis | actinic keratosis | Paclitaxel (NPC208553) | NP level |
NCT01011075 | Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05185869 | SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00672295 | PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT04698941 | Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02465593 | A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01770301 | Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR) | sex cord-gonadal stromal tumor | Paclitaxel (NPC208553) | NP level |
NCT00199797 | Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04210037 | Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00023907 | Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT02590367 | Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy | peripheral neuropathy | Fluorouracil (NPC75844) | NP level |
NCT00009750 | Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT05469061 | Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01383343 | Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003313 | Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00542451 | Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00976768 | Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00107341 | Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00369551 | Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT04572100 | Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer | oropharynx squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003587 | S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01154920 | Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00475670 | A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00278122 | Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery | cutaneous melanoma | Paclitaxel (NPC208553) | NP level |
NCT02500940 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03887442 | Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00874107 | Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01348217 | Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00176267 | Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03167177 | QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy | melanoma | Fluorouracil (NPC75844) | NP level |
NCT01620190 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05244993 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49) | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002999 | S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01467115 | Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003299 | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00696488 | Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00801736 | ERCC1 Targeted Trial | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02710734 | Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) | urinary bladder carcinoma | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT04120701 | CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01233843 | Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00064077 | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix | cervical adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00666692 | A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01525329 | Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00002735 | SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00453323 | Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00033410 | Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT05189184 | Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00033735 | Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01497470 | A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen | cancer | Paclitaxel (NPC208553) | NP level |
NCT01279681 | Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00331630 | Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00147680 | Uterine Papillary Serous Cancer (UPSC) Trial | uterine cancer | Paclitaxel (NPC208553) | NP level |
NCT02470585 | Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00039039 | Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01351350 | Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT03732508 | SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02560038 | Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer | bladder tumor | Paclitaxel (NPC208553) | NP level |
NCT00001383 | A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | renal cell carcinoma;lymphoma;ovarian cancer;breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02319304 | Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | colorectal adenocarcinoma;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04286711 | Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT03885219 | Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02446574 | Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03603834 | Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01440751 | Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery | glaucoma | Mitomycin (NPC139867) | NP level |
NCT00503906 | Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02834975 | Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00096343 | Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01220128 | Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02012062 | Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05390710 | PhI to Solid Tumors and PhII to Locally Advanced or mTNBC | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00466986 | Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00069121 | A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01264328 | Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00423696 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00752115 | Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05497778 | A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer. | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00022217 | Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT01647217 | Demodex Blepharitis Treatment Study | blepharitis | Terpin (NPC77550) | NP level |
NCT00226746 | Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT03002103 | A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT05145569 | A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00022633 | S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract | urethra cancer;urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT02607202 | A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP) | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02023593 | FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01493505 | A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers | fallopian tube cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00236899 | Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00112918 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005979 | Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03164382 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
NCT00128856 | Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02142322 | Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01941966 | A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. | anus cancer | Mitomycin (NPC139867) | NP level |
NCT04921527 | A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00254592 | Neoadjuvant Treatment of Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00174356 | PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00368992 | S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01924819 | Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00004013 | Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03600090 | Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01593020 | Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01581476 | Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial | type 1 diabetes mellitus | Paclitaxel (NPC208553) | NP level |
NCT00183911 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00941499 | Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab | cancer | Fluorouracil (NPC75844) | NP level |
NCT04540211 | A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT03975049 | Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02672475 | Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02297217 | Chemoradiotherapy for Advanced Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00691912 | Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00217737 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | Lynch syndrome;signet ring cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00884767 | Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04449549 | Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00003387 | Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00687817 | Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01205711 | Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02887313 | FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002627 | Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01248299 | Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04935359 | Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2 | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01091428 | Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer | ovarian carcinoma;breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05065801 | Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02400567 | Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04707118 | Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00021281 | Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02317874 | Testing the Addition of the Anti-Cancer Drug Talazoparib to the Combination of Carboplatin and Paclitaxel for the Treatment of Advanced Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00003377 | Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT01158144 | Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01263145 | MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01775501 | Sorafenib + mFOLFOX for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01750073 | Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03064126 | RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty | peripheral arterial disease | Paclitaxel (NPC208553) | NP level |
NCT01296763 | Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Mitomycin (NPC139867) | NP level |
NCT00344552 | Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00081042 | ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma | cutaneous melanoma | Paclitaxel (NPC208553) | NP level |
NCT00003158 | S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00955305 | Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer | large cell lung carcinoma;lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02718417 | Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00002551 | SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01851174 | Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03018080 | Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003710 | Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors | neoplasm | Mitomycin (NPC139867) | NP level |
NCT01548924 | Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02681003 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00021372 | Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Paclitaxel (NPC208553) | NP level |
NCT00003413 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02892123 | Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001) | cancer | Paclitaxel (NPC208553) | NP level |
NCT00070122 | Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00059826 | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00343239 | Docetaxel in Locally Advanced Gastric Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00615602 | Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00086996 | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00999700 | Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00966914 | Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05177796 | Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01487226 | Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT04806945 | A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00720512 | Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05294900 | Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05067530 | Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01081041 | A Study in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003003 | Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia | leukemia | Mitomycin (NPC139867) | NP level |
NCT00003680 | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05272696 | Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00024427 | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04843098 | Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03595059 | A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00006027 | Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT04723875 | Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline | cervical adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT03981796 | A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00006120 | Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00470301 | Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00003717 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00660842 | Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00268450 | Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT04683939 | Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors | cholangiocarcinoma;gastric cancer;pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00607048 | Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02012192 | A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00776724 | Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00460317 | MONET1-MOtesanib NSCLC Efficacy and Tolerability Study | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003317 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02452853 | HR Combined With FOLFOX4 for HCC With PVTT | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02054884 | F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma | Merkel cell skin cancer | Paclitaxel (NPC208553) | NP level |
NCT01333709 | Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03189446 | Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03299660 | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03017326 | Paediatric Hepatic International Tumour Trial | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT00022620 | Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT01170663 | A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01183559 | A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery | stomach neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00093119 | Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT01688336 | FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00023673 | Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03201861 | Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00023868 | Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | colorectal carcinoma | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT05322720 | HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01069328 | Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00768469 | Study Evaluating Safety And Tolerability, Solid Tumor | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03116152 | Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00611858 | Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02375672 | Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00288041 | Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT03690739 | Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05166772 | Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy,HAIC)in the First-line Treatment of Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00049257 | Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT04185883 | Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01204996 | A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid Tumors | cancer | Paclitaxel (NPC208553) | NP level |
NCT02477826 | An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04994236 | Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03008512 | A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib | hepatocellular carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00541112 | Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03924544 | Decorin in Sub Scleral Trabeculectomy | glaucoma | Mitomycin (NPC139867) | NP level |
NCT01227707 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00068757 | Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003644 | Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01485848 | A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT05371301 | Effect of Albumin-bound Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian, Fallopian Tube or Peritoneal Cancer: A Phase 2 Single Center Clinical Trial | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04694183 | The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01015222 | Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT00003732 | Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01527864 | Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01930292 | Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03193918 | Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01702844 | Single Arm on the Tolerability of Weekly Nab-paclitaxel | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02456714 | Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00128037 | Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806) | lung neoplasm | Mitomycin (NPC139867) | NP level |
NCT00981656 | Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT04979585 | Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT04428333 | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | head and neck neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01126216 | Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00002570 | Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04572542 | Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02047513 | Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00034177 | Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium | urogenital neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03475615 | A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT03490292 | Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT03928314 | Study of ORIC-101 in Combination With Anticancer Therapy | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03762564 | Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04498689 | Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00193882 | Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01413750 | Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003160 | Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00025389 | Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01383707 | A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02651727 | Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003089 | Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00152477 | A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00303758 | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003127 | S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00002507 | Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer | carcinoma;head and neck malignant neoplasia | Mitomycin (NPC139867) | NP level |
NCT04390958 | Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00903942 | Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02701088 | Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life | anus cancer | Mitomycin (NPC139867) | NP level |
NCT05179889 | Adjuvant FOLFOXIRI for High-risk Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01967043 | A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00709761 | Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02858206 | Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00030459 | Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma | mesothelioma | Mitomycin (NPC139867) | NP level |
NCT03037541 | Cryosurgery and Cream Combination for Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00001499 | Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02106572 | Therapeutic Instillation of Mistletoe | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02138812 | A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT02551432 | Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04937738 | Perioperative Chemotherapy in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02973685 | HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02155088 | BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00215514 | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003835 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04005339 | NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT04617067 | Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002893 | Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04258644 | Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01732640 | A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00002828 | Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02723331 | Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00005581 | Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00310011 | Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00995293 | Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00515073 | Papillary Serous Carcinoma of the Endometrium | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT04258657 | Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01646762 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma | multiple myeloma | Paclitaxel (NPC208553) | NP level |
NCT00100139 | Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00149201 | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
NCT00016198 | Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04859582 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00026273 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02124317 | Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01998347 | Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01463072 | Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00611962 | Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin | germ cell tumor | Paclitaxel (NPC208553) | NP level |
NCT00004913 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01560949 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04130854 | INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03467178 | Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00055679 | Combination Chemotherapy in Treating Women With Stage I Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00005028 | Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT04722133 | Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00289263 | Maintenance Chemotherapy in Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03126812 | Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT01206465 | Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01522989 | PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03286244 | Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00577109 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003281 | Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02767219 | The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery | glaucoma | Fluorouracil (NPC75844) | NP level |
NCT00915850 | Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00069953 | Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | esophageal cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT05173987 | Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15) | endometrial neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00003376 | Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium | urethra cancer;urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00580073 | Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00091312 | Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00499603 | Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003440 | Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00004077 | Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer | testicular neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00495170 | Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00309478 | Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05348811 | HAIC Combined With Donafenib and Sintilimab for Unresectable ICC | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00001498 | A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02355119 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03125902 | A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00069095 | A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006468 | Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00010062 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03736720 | Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin | pancreatic endocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00849472 | Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00318643 | Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04831320 | Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01820325 | Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03272477 | Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02414685 | First Line TIP in Poor Prognosis TGCTs. | germ cell tumor | Paclitaxel (NPC208553) | NP level |
NCT00748163 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02050009 | Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ovarian serous cystadenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00550537 | Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01249443 | Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection | anus cancer;hypopharyngeal carcinoma;verrucous carcinoma;laryngeal squamous cell carcinoma;malignant epithelial tumor of ovary;oropharyngeal carcinoma;esophageal cancer;gastric cancer;HIV infection;non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00337532 | A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT04308837 | A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT02121990 | Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT00316888 | Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT03400306 | A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04035473 | A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00004055 | Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03136055 | Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas | neuroendocrine carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01684878 | ICON8: Weekly Chemotherapy in Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00023842 | BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT01196234 | Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00313872 | Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02050178 | Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02795988 | A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03179904 | FASN Inhibitor TVB-2640 and Trastuzumab in Combination With Paclitaxel or Endocrine Therapy for the Treatment of HER2 Positive Metastatic Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00019812 | Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2 | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00384176 | First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT03067792 | FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002814 | Combination Chemotherapy for Patients With Brain Cancer | Central Nervous System Neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02299999 | SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer | breast cancer | Mitomycin (NPC139867) | NP level |
NCT00959387 | Induction Chemotherapy for Advanced Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT05145218 | Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00075712 | Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT04221828 | Trial of NanoPac Focal Therapy for Prostate Cancer | prostate adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00548548 | A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003392 | High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02392637 | Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers | gallbladder cancer;intrahepatic cholangiocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00004253 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00497497 | A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01094964 | Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT03803254 | HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04135781 | Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00691054 | Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04683315 | PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00280150 | Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02901236 | Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma | glaucoma | Mitomycin (NPC139867) | NP level |
NCT00006111 | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT00524303 | EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01769391 | A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04661696 | Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00003543 | Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02827201 | FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT01026116 | Treatment With Pazopanib for Neoadjuvant Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01920269 | Intravesical Adjuvant Electromotive Mitomycin-C | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT01276379 | Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00326456 | MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT01225523 | Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus | esophageal squamous cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03130790 | Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003733 | Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04338399 | The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT04341883 | Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02820857 | Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00803556 | Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03415802 | Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04165772 | Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003624 | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | cervical cancer;endometrial cancer;fallopian tube cancer;ovarian cancer;peritoneum cancer;sarcoma | Paclitaxel (NPC208553) | NP level |
NCT04266249 | CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00331422 | Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT02016417 | Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02158520 | Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery | cutaneous melanoma;metastatic melanoma | Paclitaxel (NPC208553) | NP level |
NCT00034164 | Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00001426 | A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00452803 | Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC) | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00042874 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00807612 | QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04926753 | Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00974818 | Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00748553 | A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00006229 | Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01091428 | Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction | fallopian tube cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00391118 | Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") | Fallopian Tube Carcinoma;ovarian cancer;peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02890511 | A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT04526470 | Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00006245 | Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT01465451 | Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01938846 | BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03342352 | Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003287 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00309569 | Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01679327 | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00011999 | Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT05229497 | FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC | cancer | Fluorouracil (NPC75844) | NP level |
NCT00003216 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01704690 | Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00839111 | Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01930552 | A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03751761 | GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT03606967 | Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02071069 | Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04548440 | Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00054392 | Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03410030 | Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02446652 | Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT01868984 | Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis | stricture | Paclitaxel (NPC208553) | NP level |
NCT00006377 | Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT03554044 | T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00054548 | Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00245154 | Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02036164 | Adjuvant Chemotherapy for Locally Advanced Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00071188 | ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04897854 | Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00508625 | A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00881101 | Clinical Study of Liposomal Paclitaxel in Chinese Patients | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03635567 | Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT04278287 | Chemoradiotherapy in Unresectable Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT02272790 | Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Fallopian Tube Carcinoma;ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01634555 | A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00006374 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00721916 | Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02178709 | A Phase II Study of Neoadjuvant FOLFIRINOX | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003899 | Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00637897 | Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01447706 | Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00255762 | Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00609765 | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003691 | Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT02024009 | Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 | pancreatic neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03563170 | QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03601897 | A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04749108 | Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02041481 | MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01978184 | Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03443492 | SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01055028 | Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma | angiosarcoma | Paclitaxel (NPC208553) | NP level |
NCT00004003 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01964534 | Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03780634 | HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00970580 | A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00006366 | Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03714555 | Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03085056 | Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer | thyroid cancer | Paclitaxel (NPC208553) | NP level |
NCT00003701 | Combination Chemotherapy in Treating Patients With Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00275119 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02021422 | A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05422794 | Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03588039 | Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02578368 | Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00045747 | UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00290537 | Phase II Study of ZD6474 in Advanced NSCLC | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00001579 | A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors | lymphoma | Fluorouracil (NPC75844) | NP level |
NCT01611857 | Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02103062 | Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer | colorectal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04550260 | Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04990037 | A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00066846 | Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00176254 | Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05052099 | Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00265811 | Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01332656 | Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00653939 | A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01862328 | Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04127019 | Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00471484 | Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT00473889 | A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04228601 | A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04046016 | A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02419495 | Selinexor With Multiple Standard Chemotherapy or Immunotherapy Regimens in Treating Patients With Advanced Malignancies | cutaneous melanoma;Fallopian Tube Carcinoma;metastatic melanoma;non-small cell lung carcinoma;ovarian carcinoma;breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05047991 | Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03502343 | Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02884128 | A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00296608 | Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00329641 | Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye | melanoma | Paclitaxel (NPC208553) | NP level |
NCT03300544 | Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02855788 | Metronomic Chemotherapy in Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00003652 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT00002692 | Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00889382 | Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00436566 | Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02106546 | Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00089024 | Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004921 | High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00042809 | Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00551213 | A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03829722 | Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer | oropharynx squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01985841 | Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00002716 | Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01270438 | Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04251533 | A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05044871 | Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT05095467 | HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction | stomach neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01486602 | Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00002783 | Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03855384 | Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN) | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03092895 | A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
NCT00874848 | Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00058474 | Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03143153 | A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
NCT05174169 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01583426 | Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03699319 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01966003 | Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03598270 | Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02182245 | Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies | Genital neoplasm, female | Paclitaxel (NPC208553) | NP level |
NCT00238160 | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT00003035 | Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02551159 | Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00991796 | CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00970996 | Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00472810 | Ologen (OculusGen)-Glaucoma MMC Control in Pakistan | glaucoma | Mitomycin (NPC139867) | NP level |
NCT00057928 | S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT04541108 | Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00356681 | A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00785291 | Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02767375 | Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00944047 | Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00151060 | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT01340131 | CKD-828 (40/5mg) Pharmacokinetic Study | hypertension | Paclitaxel (NPC208553) | NP level |
NCT03604965 | GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00005806 | Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00151034 | Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer | urogenital neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00941655 | Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02948075 | Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC). | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00070564 | S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01938833 | Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer | inflammatory breast carcinoma;male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00820547 | Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00002969 | S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03309150 | ATRi Transition Rollover Study | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00337376 | A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers | cancer | Paclitaxel (NPC208553) | NP level |
NCT04229459 | Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01010945 | Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01616303 | A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00813137 | FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00525759 | Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03668730 | Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00343083 | Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442) | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01442649 | Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02134067 | Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00611507 | A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00281788 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | pancreatic carcinoma | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT00662129 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03326947 | Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02405585 | Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03484195 | Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02101021 | Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01566240 | Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT03314740 | Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00088088 | STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00798252 | Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers | cancer | Paclitaxel (NPC208553) | NP level |
NCT00226915 | Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01354717 | Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT02436993 | Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003120 | S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00002734 | Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00657878 | Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03038100 | A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00679029 | Combination Chemotherapy and Bevacizumab in Treating Women With HER2/Neu-Negative Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003088 | Combination Chemotherapy in Treating Patients With Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01115517 | Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery | pterygium | Mitomycin (NPC139867) | NP level |
NCT00021073 | Combination Chemotherapy in Treating Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00392704 | Treatment of Head & Neck Cancer With Chemotherapy and Radiation | head and neck malignant neoplasia | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00079430 | Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | ovarian serous cystadenocarcinoma;endometrioid carcinoma;fallopian tube cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00038246 | Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT01200992 | Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer | in situ carcinoma;Transitional Cell Carcinoma | Mitomycin (NPC139867) | NP level |
NCT02570711 | Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05357846 | PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00788931 | A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01008150 | Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04652076 | GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab | cervical carcinoma;endometrial carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04675983 | A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00320541 | A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02325986 | Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03370406 | Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005635 | Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03740165 | Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02419495 | Selinexor With Multiple Standard Chemotherapy or Immunotherapy Regimens in Treating Patients With Advanced Malignancies | renal cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT04731038 | Combination Therapy for First Line Treatment of Advanced Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT01142414 | Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00005059 | Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02682693 | Denosumab as an add-on Neoadjuvant Treatment (GeparX) | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00732836 | Hepatic Arterial Infusion (HAI) of Abraxane | liver cancer | Paclitaxel (NPC208553) | NP level |
NCT03224221 | Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03869034 | HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003585 | Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT00022230 | Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04158635 | Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01455532 | A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00002689 | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002972 | Paclitaxel in Treating Patients With Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01542931 | TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004093 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04692051 | A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer | biliary tract cancer | Paclitaxel (NPC208553) | NP level |
NCT00080990 | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02125513 | Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00602797 | Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00849264 | Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients | thrombotic disease;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00036868 | Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04592211 | Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer With HRR Mutation and MSS | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT02756013 | Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0 | urogenital neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01024101 | Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00142350 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04807972 | Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02494973 | Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002884 | Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04523818 | Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00112697 | Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02005315 | A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00049101 | Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04876313 | An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo) | urinary bladder carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00084565 | Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT02399137 | A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03410784 | A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02767557 | Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04211012 | A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma | urothelial carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04148911 | A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04584112 | A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003614 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00003594 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01167712 | Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | endometrioid carcinoma;Fallopian Tube Carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00001498 | A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00921531 | Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT00496028 | Phase I Study in Patients With Solid Tumours | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02942563 | Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05170438 | Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment | biliary tract cancer | Paclitaxel (NPC208553) | NP level |
NCT01608009 | [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03430882 | Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01083537 | Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04337632 | NUVOLA TRIAL Open-label Multicentre Study | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04875026 | Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00003612 | Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02969473 | Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma | neoplasm of esophagus | Fluorouracil (NPC75844) | NP level |
NCT03323463 | Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma | oropharynx squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04460352 | Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer | esophageal squamous cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT02924909 | Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00124111 | A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04527991 | Study of Sacituzumab Govitecan-hziy (IMMU-132) Versus Treatment of Physician's Choice in Participants With Metastatic or Locally Advanced Unresectable Urothelial Cancer | urogenital neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00408070 | Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00273507 | Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00498953 | Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05263219 | DEB-TACE+HAIC vs. HAIC for Large HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03056833 | A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00840450 | Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01650376 | A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT05251038 | Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT05446467 | Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01526135 | Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00020787 | Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02934464 | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers | stomach neoplasm | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT03426904 | Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00006051 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00129727 | Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01868022 | Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00024414 | DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00268333 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00616967 | Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04868708 | A Study of AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02364999 | A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02289456 | Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2 | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00337389 | Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00096278 | Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00129389 | FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03246074 | QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03861702 | Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01765582 | Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00502203 | Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus | mixed neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00307255 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00609622 | Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04858009 | Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01778803 | A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00002913 | Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer | ovarian serous cystadenocarcinoma;endometrioid carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00368875 | Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00123318 | A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04195828 | Camrelizumab Combined With Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00828841 | Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05035381 | PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT02515734 | A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00708812 | Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00052559 | Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02997332 | Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03136406 | QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT00070278 | Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00003799 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01493843 | Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04241185 | Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) | bladder tumor | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT00585689 | Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00068692 | Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer | mucinous carcinoma;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02412371 | A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01017640 | Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors | neoplasm | Mitomycin (NPC139867) | NP level |
NCT02559674 | QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03252808 | Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients With Unresectable Pancreatic Cancer. | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03328234 | Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03 | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00953394 | 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02023710 | Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00883116 | A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00003555 | Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00768859 | Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04764227 | Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00193297 | Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00002490 | Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00003284 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01494688 | A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02283372 | Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03038100 | IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00479674 | Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04257448 | Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01779050 | Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01326000 | A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04241276 | Phase IIb Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02931890 | Multicentric Randomised Trial for Resectable Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT03167177 | QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00098982 | Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00462423 | Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00121992 | Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03117933 | Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02822157 | Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer | malignant epithelial tumor of ovary | Paclitaxel (NPC208553) | NP level |
NCT04138212 | Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903) | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01327521 | Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma | hepatocellular carcinoma | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT00144053 | A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02383212 | Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel | cancer | Paclitaxel (NPC208553) | NP level |
NCT00003812 | Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03763123 | Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03830606 | The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma | biliary tract cancer | Paclitaxel (NPC208553) | NP level |
NCT03381352 | Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer | anus cancer | Mitomycin (NPC139867) | NP level |
NCT00237900 | Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04883281 | A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00537823 | Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05235542 | A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT00024271 | Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer | mesothelioma | Mitomycin (NPC139867) | NP level |
NCT02138383 | Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03935256 | Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00828009 | BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00559741 | Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003342 | Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00642759 | Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01730586 | Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas | colorectal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01159418 | LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03278015 | Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01671488 | A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer | anus cancer | Mitomycin (NPC139867) | NP level |
NCT03331640 | A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00334763 | Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00976573 | Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma | cutaneous melanoma | Paclitaxel (NPC208553) | NP level |
NCT04753879 | Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00844649 | Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00016913 | Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00176241 | Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00616031 | Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01489865 | ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03281369 | A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) | gastric adenocarcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00020501 | Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04175912 | Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver | hepatocellular carcinoma;intrahepatic cholangiocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00568451 | Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma | cutaneous melanoma | Paclitaxel (NPC208553) | NP level |
NCT01667211 | Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00820170 | Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04757363 | A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00654836 | Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03704077 | An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01953536 | Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02115152 | Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02107937 | Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma | malignant epithelial tumor of ovary | Paclitaxel (NPC208553) | NP level |
NCT00110084 | ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00736944 | Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT01593306 | Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix | carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01941641 | Colon Neoadjuvant FOLFOXIRI Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003558 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03393884 | Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00466960 | Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy | ovarian serous cystadenocarcinoma;endometrioid carcinoma;fallopian tube cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00417209 | Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02622074 | Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01593228 | Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00006248 | S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00191646 | An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy | Fallopian Tube Carcinoma;ovarian neoplasm;peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02279732 | Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT04472429 | Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04329949 | Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00915369 | A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04643405 | APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02351219 | FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00811447 | Taxotere New Indication - Gastric Cancer Treatment Registration Trial | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02016209 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02413320 | Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00667251 | Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00024349 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT03574779 | A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00054028 | Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00721513 | Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05394415 | Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00570531 | Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma | esophageal cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01374425 | Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00066716 | Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00017303 | Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT01198392 | Trial of S-1 Plus Cisplatin in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00054587 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00933803 | Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03942068 | Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00003130 | Paclitaxel in Treating Women With Recurrent Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03693677 | First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI | pancreatic carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT03469479 | Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05015621 | A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00532857 | Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01994031 | Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00004202 | Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00003240 | Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | lung cancer | Mitomycin (NPC139867) | NP level |
NCT00003558 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00246571 | Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02172846 | Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03766425 | Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy. | glaucoma | Mitomycin (NPC139867) | NP level |
NCT00003105 | Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT02073968 | PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01263171 | Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00112658 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02784288 | Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00089297 | Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT01375816 | Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02704520 | Magnetic Resonance Tumour Regression Grade as Biomarker for Stratified Management of Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05024513 | Biliary Drainage Plus HAIC in Locally Advanced pCCA | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05328336 | Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT03718624 | A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00005612 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00028938 | Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00002568 | Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02980965 | Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00265850 | Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00098787 | Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01970722 | Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer | Fallopian Tube Carcinoma;ovarian carcinoma;uterine neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04249167 | Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00592501 | Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01326767 | Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01632306 | A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT04282109 | Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX) | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00349076 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02468557 | Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT02125513 | Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer | Fallopian Tube Carcinoma;peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02133612 | Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00154700 | Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT02617849 | Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT00003004 | Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01650428 | Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003054 | Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus | sarcoma | Paclitaxel (NPC208553) | NP level |
NCT00779714 | Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC | melanoma | Paclitaxel (NPC208553) | NP level |
NCT05108870 | TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers | oropharynx squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01419548 | ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03250832 | Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00628810 | Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01111604 | A Study of Ramucirumab or Icrucumab in Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003063 | Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02608229 | BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03398655 | Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00954642 | A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors | cancer | Paclitaxel (NPC208553) | NP level |
NCT00514020 | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01873326 | Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | germ cell tumor | Paclitaxel (NPC208553) | NP level |
NCT00876395 | Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03487016 | First-line Therapy in Metastatic PDAC | pancreatic carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00003065 | Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00576225 | CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01285557 | Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01881230 | Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02301091 | Combine TACE and RFA Versus TACE Alone for HCC With PVTT | hepatocellular carcinoma | Mitomycin (NPC139867) | NP level |
NCT00581971 | Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer | cancer | Paclitaxel (NPC208553) | NP level |
NCT04561817 | To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer | ovarian neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00918528 | Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy | Urethral stricture | Mitomycin (NPC139867) | NP level |
NCT01911598 | A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) | head and neck malignant neoplasia | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT02283489 | Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | upper aerodigestive tract neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00929162 | A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00252798 | ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02423226 | Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003881 | Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00303628 | Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00008060 | Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05201430 | Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05024734 | Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT03110510 | FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT01253525 | Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas | adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT03777462 | Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1 | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02677597 | Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05255471 | Antitumor Activity of Neoadjuvant Chemotherapy With or Without BINTRAFUSP ALFA in Patients With Metastatic Advanced Stage Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT05239741 | Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03776812 | A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer. | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02826837 | LEAC-102 for Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT02389985 | Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00331097 | ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04879368 | RegoNivo vs Standard of Care Chemotherapy in AGOC | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT03169738 | QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04808323 | MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03563248 | Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01912625 | Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03504423 | Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02449655 | Trial of AZD5363 Plus Paclitaxel /AZD2014 Plus Paclitaxel in Biomarker Negative (PIK3CA/MEK/RAS/TP53/MET) Gastric Adenocarcinoma Patients as Second-line Chemotherapy | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01231802 | Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02152137 | Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer | thyroid cancer | Paclitaxel (NPC208553) | NP level |
NCT02630264 | E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck | upper aerodigestive tract neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00009763 | Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02569242 | Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT00561119 | Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01248949 | A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03391843 | Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01253681 | A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02141295 | A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01149174 | Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT02420314 | Pharmacological Ascorbate for Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00950300 | A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04997837 | Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03126812 | Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04811924 | The Effect of Mitomycin C on Corneal Haze and Scarring After Corneal Crosslinking in Keratoconus Patients | keratoconus | Mitomycin (NPC139867) | NP level |
NCT01649336 | TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00434252 | A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma | melanoma | Paclitaxel (NPC208553) | NP level |
NCT02215447 | A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas | neuroendocrine carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00188266 | Study of Adjuvant Radiochemotherapy for Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01889420 | Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma | multiple myeloma | Paclitaxel (NPC208553) | NP level |
NCT00003998 | Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00085358 | Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) | ovarian serous cystadenocarcinoma;endometrioid carcinoma;fallopian tube cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00541125 | G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00848718 | A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003) | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02040454 | Paclitaxel for the Treatment of Distal Radial Artery Arteriovenous Access Fistula Stenosis (PaciFIST-2) | stricture | Paclitaxel (NPC208553) | NP level |
NCT02705196 | LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03082209 | First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT03915444 | Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT03806309 | Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01216644 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00868491 | Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00209703 | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02412722 | Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT02713386 | Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT00433420 | Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00335816 | Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01366131 | Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02027428 | Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer | squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04068103 | Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02919787 | Nordic Pancreatic Cancer Trial (NorPACT) - 1 | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00300885 | A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00085501 | S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00022191 | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer | urethra cancer;urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT01604863 | A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT00738699 | First Line Tx Stage III Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04084158 | A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01491204 | Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01216111 | Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02485548 | Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04159155 | A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00417976 | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01746771 | A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00034151 | Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02514278 | Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00527735 | Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) | small cell lung carcinoma;non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02159820 | Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04864782 | QL1604 Plus Chemotherapy Versus Chemotherapy in Subjects With Stage ⅣB, Recurrent, or Metastatic Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00584909 | A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus | uterine cancer | Paclitaxel (NPC208553) | NP level |
NCT00622466 | Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02563054 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01617928 | A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02403895 | AZD2014 and Weekly Paclitaxel in Squamous NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01301716 | A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors | cancer | Paclitaxel (NPC208553) | NP level |
NCT01297803 | Comparison of Two Method Antimetabolites Application on Corneal Function in Trabeculectomy Surgery | glaucoma | Mitomycin (NPC139867) | NP level |
NCT00003092 | Paclitaxel in Treating Older Patients With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00212589 | Patients Preference for Oral or i.v. Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04085276 | Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00052351 | Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03989310 | An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00668616 | Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT05013697 | TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer. | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02520154 | Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00002917 | Paclitaxel in Treating Patients With Early-Stage Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT02262897 | The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00544648 | Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00353717 | Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2 | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00194753 | Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03957590 | Study of Tislelizumab (BGB-A317) Versus Placebo in Combination With Chemoradiotherapy in Participant With ESCC | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01274962 | A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05412082 | SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002883 | Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01303926 | Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04217954 | HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00003133 | Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT03503136 | Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01612351 | Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03564691 | Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001) | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03085914 | A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) | neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00298415 | Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00513695 | Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer | inflammatory breast carcinoma;male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00046527 | Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer | metastasis;breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00319839 | Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT01896531 | A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00520013 | Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00807573 | Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00136175 | Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT05000892 | Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms | salivary gland cancer | Paclitaxel (NPC208553) | NP level |
NCT01293630 | A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00028860 | Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00042302 | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00591851 | Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT04929041 | Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative | lung adenocarcinoma;squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00004242 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02291289 | A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04155671 | POF Versus FOLFOX Plus IP Paclitaxel in AGC | gastric cancer | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT02047500 | Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02720068 | Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03940196 | Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03394885 | Study of GEN-1 With NACT for Treatment of Ovarian Cancer (OVATION 2) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00513292 | Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03002064 | Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01969955 | Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer | squamous cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003084 | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00479817 | Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00209625 | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002498 | Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01285466 | A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00493025 | Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | esophageal cancer | Paclitaxel (NPC208553) | NP level |
NCT01705483 | A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) | cancer | Paclitaxel (NPC208553) | NP level |
NCT00639522 | Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma | gastric carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03273595 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03639246 | A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT02616601 | Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT03635489 | Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00003449 | Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03756818 | TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors | ovarian carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02560220 | MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients | chronic kidney disease | Mitomycin (NPC139867) | NP level |
NCT04481009 | A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02226757 | Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02210559 | A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02270606 | Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00811993 | A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00864318 | Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis | germ cell tumor | Paclitaxel (NPC208553) | NP level |
NCT02630199 | A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer | cancer | Paclitaxel (NPC208553) | NP level |
NCT00023751 | Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00429299 | Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00003242 | Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04844385 | Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00971945 | Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00992199 | Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00004934 | Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT02873598 | A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00786552 | Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer | thyroid cancer | Paclitaxel (NPC208553) | NP level |
NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00626405 | Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery | cutaneous melanoma | Paclitaxel (NPC208553) | NP level |
NCT04483076 | Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT02225652 | A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00533585 | BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02937116 | A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT02112552 | Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer | uterine neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00311636 | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01693276 | Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03912415 | Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA) | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT02128100 | Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04973904 | Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT05281003 | Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05378919 | Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00600340 | 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00602602 | Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00427570 | Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00028990 | Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00979082 | Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer | peripheral neuropathy | Paclitaxel (NPC208553) | NP level |
NCT00004011 | S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00566540 | Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00007904 | Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00967616 | Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02268695 | Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03635489 | Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT04495088 | Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03306121 | TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01490866 | A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04393584 | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00005026 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT02296671 | Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02319889 | Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04170530 | Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04821284 | Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT03029611 | Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC). | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT00002896 | Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03810872 | An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00486668 | A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00033644 | Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus | sarcoma | Mitomycin (NPC139867) | NP level |
NCT03169764 | QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | head and neck squamous cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03740165 | Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) | peritoneal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00894569 | Paclitaxel/Carboplatin With or Without Cetuximab in CUP | carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00661167 | Phase II Study of ABI-007 for Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT01171482 | Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT03766607 | Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00369070 | A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01376453 | Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00079287 | Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01336062 | Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00294762 | Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00063258 | Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00583349 | Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT01167725 | Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844);Mitomycin (NPC139867) | NP level |
NCT02415699 | DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02846428 | To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00083057 | Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT01935492 | 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02138617 | Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02615730 | PI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma | gastric adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00998192 | A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung | squamous cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02834975 | Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00196872 | A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00014573 | Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer | Central Nervous System Neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01494506 | Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04469556 | Pancreatic Adenocarcinoma Signature Stratification for Treatment | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT02891083 | Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04794699 | Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02340117 | Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00004054 | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT00028587 | PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03783442 | A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT01628211 | Second Look Laparoscopy in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02976909 | Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00850577 | Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05024097 | A Phase II Study to Test the Efficacy of AB928 (Dual Adenosine Receptor Antagonist) and AB122 (a PD1 Checkpoint Inhibitor) in Combination With Short Course Radiotherapy and Consolidation Chemotherapy for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03330106 | A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT04827953 | Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01229930 | Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT01441349 | Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01653912 | Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT05241249 | Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00467012 | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02413853 | Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03939962 | Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01755845 | Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT03964753 | Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00004137 | S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01205022 | Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05319639 | Phase I Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab | gastric cancer | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT04769414 | Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01654146 | Dose-finding Study in Platinum-Resistant Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01222052 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04081389 | Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer | breast carcinoma in situ | Paclitaxel (NPC208553) | NP level |
NCT00912639 | A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01269216 | A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02648711 | Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01181401 | InductionChemo-Radio-Antibody-Treatment | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00731380 | A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer | head and neck malignant neoplasia | Paclitaxel (NPC208553) | NP level |
NCT00544362 | Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00781612 | A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies | metastasis | Paclitaxel (NPC208553) | NP level |
NCT04356170 | Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05193292 | Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02761694 | Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase | cancer | Paclitaxel (NPC208553) | NP level |
NCT02632305 | A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer | biliary tract cancer | Paclitaxel (NPC208553) | NP level |
NCT03603756 | SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01524094 | Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004931 | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03047265 | Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03110926 | Induction Chemotherapy for Locally Advanced Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00873275 | Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00303771 | Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01253681 | Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT03603184 | Atezolizumab Trial in Endometrial Cancer - AtTEnd | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT02930902 | Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01739218 | A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00595972 | Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05007145 | PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03778593 | FOLFIRINOX for 2nd-line Treatment of BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT01924533 | Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer. | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT03699449 | Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT04180384 | A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03169790 | QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL | non-Hodgkins lymphoma | Paclitaxel (NPC208553) | NP level |
NCT03167112 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03361319 | Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT01160601 | Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01739894 | Feasibility Study of Intraperitoneal Paclitaxel | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00020007 | Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT03776812 | Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Fallopian Tube Carcinoma | Paclitaxel (NPC208553) | NP level |
NCT05062889 | Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01862081 | A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT02982395 | Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC | urinary bladder cancer | Mitomycin (NPC139867) | NP level |
NCT00733889 | A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02603679 | Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases | breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003086 | Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003994 | Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT03825861 | Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02250326 | Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00072319 | Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT01240655 | A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT01402271 | A Study of MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT03563170 | QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine | hepatocellular carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003742 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00400179 | A Safety and Efficacy Study in Patients With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02455141 | A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00630032 | Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00026364 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00093756 | Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01969578 | Androgen Deprivation Therapy in Advanced Salivary Gland Cancer | salivary gland cancer | Paclitaxel (NPC208553) | NP level |
NCT01560104 | A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT04001569 | AZD8186 and Paclitaxel in Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02527772 | Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03240016 | Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer | urothelial carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00004859 | Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01271725 | Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03386838 | An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00483782 | Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00448305 | Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05344742 | A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03081143 | Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy | gastric carcinoma | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00003422 | Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01434069 | Phase I Trial of Combination of FOLFIRI and SOM 230 | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04213937 | Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387085 | QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04161755 | Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03168607 | Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01281150 | Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors | male breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01014351 | Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma | metastatic melanoma | Paclitaxel (NPC208553) | NP level |
NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01003158 | Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT05342636 | A Study of Combination Therapies With Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer (MK-3475-06A) | esophageal squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003777 | Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01662869 | A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05383196 | Onvansertib + Paclitaxel In TNBC | inflammatory breast carcinoma | Paclitaxel (NPC208553) | NP level |
NCT02978495 | Neoadjuvant Carboplatin in Triple Negative Breast Cancer | Hereditary breast and ovarian cancer syndrome | Paclitaxel (NPC208553) | NP level |
NCT00687687 | Evaluation of Paclitaxel (Taxol, NSC | Uterine Carcinosarcoma | Paclitaxel (NPC208553) | NP level |
NCT00002755 | Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05218889 | Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer | pancreatic carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00390611 | Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00521781 | Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer | prostate adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT04853082 | Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution | Hepatic steatosis | Limonene (NPC76145) | NP level |
NCT02392507 | A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00093145 | Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00004005 | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01473303 | Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03291899 | Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00062179 | Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00129922 | Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04358354 | Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00045630 | S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium | urethra cancer;urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00001387 | Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02383966 | Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04802980 | A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02369458 | Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies | head and neck squamous cell carcinoma | Mitomycin (NPC139867) | NP level |
NCT00284752 | Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT01498783 | Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma | central nervous system cancer;ependymoma | Fluorouracil (NPC75844) | NP level |
NCT01183559 | A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery | esophageal carcinoma | Fluorouracil (NPC75844);Paclitaxel (NPC208553) | NP level |
NCT04742036 | Capivasertib China PK Study | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT05081687 | Brazilian Total Neoadjuvant Therapy Trial | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05017012 | A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of MK-3475A (Pembrolizumab Formulated With MK-5180) In Advanced Solid Tumors (MK-3475A-C18) | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03991962 | Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04015661 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC | nasopharyngeal neoplasm | Paclitaxel (NPC208553) | NP level |
NCT03722498 | Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00068575 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02312661 | Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01235897 | MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies | cancer | Paclitaxel (NPC208553) | NP level |
NCT05332002 | A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
NCT00270543 | An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004901 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02482441 | A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00006276 | Micellar Paclitaxel to Treat Severe Psoriasis | psoriasis | Paclitaxel (NPC208553) | NP level |
NCT01644825 | A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT01418222 | FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03989336 | Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00971932 | Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04176952 | PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer | neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT03443661 | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04603846 | A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma | urothelial carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00003378 | Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer | ovarian cancer;peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT04003792 | Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00933374 | Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma | urinary bladder cancer | Paclitaxel (NPC208553) | NP level |
NCT00661193 | S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT01454102 | Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03579771 | Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer | intrahepatic cholangiocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT02573493 | Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) | head and neck squamous cell carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00825201 | First Line Tx Stage III Ovarian Cancer | peritoneum cancer | Paclitaxel (NPC208553) | NP level |
NCT00003402 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | leukemia;lymphoma | Paclitaxel (NPC208553) | NP level |
NCT03263741 | Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer | gastric cancer | Paclitaxel (NPC208553) | NP level |
NCT05083247 | Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma | pancreatic neoplasm | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00660270 | Chemotherapy and Radiation Following Pancreatic Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003927 | Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03340896 | Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03015675 | IV Ascorbic Acid in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00040794 | Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | lung adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00004873 | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00550771 | Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy. | breast neoplasm | Paclitaxel (NPC208553) | NP level |
NCT02028806 | mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00795340 | Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00034190 | Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma | colorectal adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03607656 | The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00278694 | Oxaliplatin and 5-FU Based Preoperative Chemoradiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01324141 | Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer | anus cancer | Mitomycin (NPC139867);Fluorouracil (NPC75844) | NP level |
NCT00467142 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00686322 | Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT01649947 | Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II | non-small cell lung carcinoma | Paclitaxel (NPC208553) | NP level |
NCT03462212 | Study of GEN-1 With NACT for Treatment of Ovarian Cancer (OVATION 2) | fallopian tube cancer | Paclitaxel (NPC208553) | NP level |
NCT02004093 | EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer | ovarian cancer | Paclitaxel (NPC208553) | NP level |
NCT00478946 | A Study of Picoplatin in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00384826 | Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma | bronchoalveolar adenocarcinoma | Paclitaxel (NPC208553) | NP level |
NCT00208936 | Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus | gastrointestinal disease | Paclitaxel (NPC208553);Fluorouracil (NPC75844) | NP level |
NCT00077246 | ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer | lung cancer | Paclitaxel (NPC208553) | NP level |
NCT00003549 | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | Merkel cell skin cancer | Fluorouracil (NPC75844) | NP level |
NCT01411410 | Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00891605 | Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00005847 | Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | prostate cancer | Paclitaxel (NPC208553) | NP level |
NCT03548961 | Organ Preservation in Early Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00846027 | A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT05227664 | A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer | triple-negative breast cancer | Paclitaxel (NPC208553) | NP level |
NCT00016341 | Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00357149 | Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02798536 | Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma | mesothelioma | Paclitaxel (NPC208553) | NP level |
NCT05221658 | A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02039791 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer | cervical cancer | Paclitaxel (NPC208553) | NP level |
NCT00004173 | Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer | neoplasm | Paclitaxel (NPC208553) | NP level |
NCT00052312 | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer | endometrial cancer | Paclitaxel (NPC208553) | NP level |
NCT00394251 | Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT02429622 | Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma | esophageal carcinoma | Paclitaxel (NPC208553) | NP level |
NCT00618657 | Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting | breast cancer | Paclitaxel (NPC208553) | NP level |
NCT03705429 | Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001) | breast neoplasm | Paclitaxel (NPC208553) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
MTOR
NCT00731380,NCT00997906,NCT01126216,NCT00004901,NCT00113399,NCT03887442,NCT00460265,NCT00004094,NCT00002999,NCT00337532,NCT00868491,NCT00004089,NCT00343083,NCT00544414,NCT04356170,NCT00014118,NCT02741570,NCT00721513,NCT00002747,NCT01081041,NCT00122460,NCT01412229,NCT00003627,NCT00301028,NCT00005087,NCT03358472,NCT00002632,NCT00392704,NCT01142414,NCT03386838,NCT00004164,NCT00004097,NCT04428333,NCT00003777,NCT00959387,NCT00011999,NCT02997332,NCT00003592,NCT00006051,NCT00095875,NCT01084083,NCT00002496,NCT01911598,NCT00100789,NCT00003193,NCT00566540,NCT00005647,NCT00002888,NCT02358031,NCT00054054,NCT01264328,NCT04338399,NCT00193284,NCT00002476,NCT00665392,NCT00002735,NCT00003637,NCT00002507,NCT00608205,NCT00004865,NCT00083057,NCT00851877,NCT00352118,NCT00971867,NCT00003327,NCT00002839,NCT00052429,NCT00022217,NCT00176241,NCT00855764,NCT03727061,NCT00003251,NCT00006248,NCT00002922,NCT00025298,NCT00498953,NCT00003888,NCT00319839,NCT02353260,NCT00833261,NCT00646659,NCT01024101,NCT01467115,NCT00089297,NCT00468169,NCT03342352,NCT00270790,NCT02013453,NCT01333085,NCT00203905,NCT00003206,NCT04883281,NCT00093665,NCT00268372,NCT00003576,NCT00352105 |
Malignant neoplasms of rectum, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92.Z |
NCT02000050,NCT00308516,NCT04749108,NCT00068692,NCT01383343,NCT01804790,NCT01333709,NCT02641691,NCT04703101
|
Endometrioid adenocarcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0SD2 |
NCT00262847,NCT00079430,NCT00466960,NCT00108745,NCT00002913,NCT02713386,NCT01167712,NCT00989651,NCT00085358
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
NCT04579224,NCT00003175,NCT00003376,NCT00022633,NCT00478361,NCT00022191,NCT00005644,NCT00045630,NCT00006111
|
Malignant neoplasms of stomach, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.Z |
NCT02048540,NCT03081143,NCT04714190,NCT00237900,NCT00639522,NCT02163291,NCT00881816,NCT00509964,NCT01748851
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
THPO,TUBB6,ITGAV,PMP22,GMNN,SMN1,TSHR,LMNA,THRB
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT05314998,NCT01218516,NCT04257448,NCT00201734,NCT05254171,NCT04935359,NCT01893294,NCT02487277,NCT05257993,NCT02993731,NCT04469556,NCT00002852,NCT03517176,NCT04134468,NCT03806309,NCT04481204,NCT03915444,NCT02468557,NCT02795988,NCT04927780,NCT00368992,NCT05472259,NCT04821284,NCT02178709,NCT02926183,NCT02732938,NCT05132504,NCT05042128,NCT02048943,NCT01506973,NCT03410030,NCT02303977,NCT04793932,NCT04752696,NCT03345810,NCT02959879,NCT01676259,NCT04539808,NCT00384826,NCT00040794,NCT00226746,NCT04929041,NCT03970252,NCT02186847,NCT04292743,NCT00021060,NCT00548548,NCT01431794,NCT02426281,NCT03361319,NCT01253525,NCT04990037,NCT01526135,NCT04634539,NCT04827953,NCT03697239,NCT04329949,NCT02243007,NCT00042835,NCT02715804,NCT00369551,NCT02501902,NCT05209074,NCT02583477,NCT02059967,NCT03331640,NCT04390763,NCT00005838,NCT03908333,NCT00955305,NCT02440958,NCT04046887,NCT03496662,NCT01578551,NCT02047513,NCT03977233,NCT04581343,NCT02723331,NCT00307723,NCT02101021,NCT02754726,NCT00054873
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
MTOR
NCT00003401,NCT02075021,NCT02985333,NCT01646762,NCT01889420,NCT00003399,NCT00003331 |
AngiosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B56 |
NCT04859465,NCT04339738,NCT03512834,NCT01055028,NCT01042379,NCT01303497,NCT03544567,NCT02212015
|
Transitional cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8EH1 |
NCT03871036,NCT04603846,NCT03658304,NCT03464734,NCT03240016,NCT03197571,NCT04211012,NCT01200992
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT01325441,NCT00337376,NCT01376310,NCT01046864,NCT01183663,NCT03498521,NCT01633970,NCT02383212,NCT01015222,NCT02640365,NCT03082209,NCT02937116,NCT02024607,NCT01110603,NCT05217069,NCT02138812,NCT00113438,NCT05235542,NCT02630199,NCT04632992,NCT00943137,NCT01187199,NCT00954642,NCT01332604,NCT01235897,NCT04611724,NCT01113476,NCT05081609,NCT02412722,NCT01653470,NCT00473720,NCT01374620,NCT00710736,NCT02483247,NCT00508326,NCT00358163,NCT02761694,NCT02240212,NCT00798252,NCT00500292,NCT03143153,NCT00002854,NCT01604863,NCT01192165,NCT01075464,NCT00581971,NCT00941499,NCT01204996,NCT04196283,NCT05329766,NCT02366949,NCT00881166,NCT01301716,NCT00479583,NCT01688791,NCT05229497,NCT01351350,NCT01579578,NCT02640755,NCT01057264,NCT04370418,NCT01705483,NCT01636622,NCT02193633,NCT03368859,NCT05332002,NCT00983541,NCT02317419,NCT02251951,NCT01497470,NCT01750918,NCT03507491,NCT02892123,NCT02327169,NCT03328494
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR
NCT02152137,NCT00603941,NCT03085056,NCT01701349,NCT00786552,NCT00507429 |
Malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
NCT00003664,NCT00024388,NCT03678883,NCT00053807,NCT00077129,NCT00053820,NCT00003585
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
GMNN,PMP22,TUBB3
NCT00980460,NCT03017326,NCT00003994,NCT04478292 |
Malignant neoplasms of cervix uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77.Z |
NCT02595554,NCT04188860,NCT02492503,NCT05290935,NCT02312804,NCT03556839,NCT04652076
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
TUBB6,ITGAV,PMP22,NPC1,SLCO1B3,LMNA,CA2
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
RAB9A,TUBB6,ITGAV,GMNN,TSHR,LMNA,CA2
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
NCT00003064,NCT00331422,NCT00031954,NCT00483782,NCT00006454,NCT00075712,NCT01146795,NCT00189553,NCT01402271,NCT00466960,NCT00052468,NCT00408070,NCT02713386,NCT00550784,NCT00993655,NCT01196741,NCT00003624,NCT00091377,NCT00008138,NCT00003944,NCT00373217,NCT00479817,NCT00004934,NCT01083537,NCT01219777,NCT00672295,NCT03038100,NCT00028743,NCT01649336,NCT00520013,NCT00085358,NCT03740165,NCT01204749,NCT02834975,NCT00079430,NCT00003385,NCT00226915,NCT03029611,NCT00466986,NCT00702299,NCT01447706,NCT00652119,NCT00838656,NCT02050009,NCT01220154,NCT01091428,NCT00189566,NCT00517621,NCT01570582,NCT02121990,NCT02012192,NCT03126812,NCT01253681,NCT00003896,NCT03635489,NCT02520154,NCT00003120,NCT00003160,NCT01493505,NCT03056833,NCT03393884,NCT03462212
|
Uterine ligament/parametrium/uterine adnexa neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C72 |
NCT00584909,NCT01650376,NCT00506779,NCT00231868,NCT00584857,NCT00147680
|
GerminomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1E13 |
NCT04581265,NCT00864318,NCT02414685,NCT01873326,NCT05455918,NCT00611962
|
Adenocarcinoma, endocervical typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH0GS9 |
NCT00295789,NCT00064077,NCT01755897,NCT04516616,NCT02020707,NCT04723875
|
Malignant neoplasms of corpus uteriDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
NCT00063999,NCT02112552,NCT00505492,NCT01970722,NCT00782041,NCT02684227
|
Urogenital cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C95-2C9Z |
NCT04527991,NCT02756013,NCT00151034,NCT02256436,NCT00034177,NCT02033993
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
GMNN,TUBB3,TSHR,SLCO1B3,THRB,CA2
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
RAB9A,TUBB6,PMP22,TUBB3,LMNA,CA2
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT04962958,NCT02069041,NCT03812770,NCT03563170,NCT02981498,NCT00559455,NCT03803254,NCT03469479,NCT01042041,NCT01171482,NCT01327521,NCT03812783,NCT02774187,NCT03008512,NCT01953406,NCT02534337,NCT02755311,NCT05476432,NCT00471965,NCT05493332,NCT03468231,NCT05166772,NCT02580253,NCT03605706,NCT05263219,NCT02767375,NCT03780634,NCT03192618,NCT00921531,NCT04175912,NCT00143403,NCT01004978,NCT03869034,NCT03722498,NCT00619541,NCT05029973,NCT05214339,NCT03048123,NCT02527772,NCT05171166,NCT02987699,NCT05033522,NCT01775501,NCT00933816,NCT02967887,NCT00183885,NCT05092373,NCT02452853,NCT02426450,NCT03780049,NCT05135364,NCT04994236,NCT00849264,NCT01055743,NCT02301091,NCT02638857,NCT03192644,NCT02973685
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT01572038,NCT03273595,NCT03997123,NCT04251533,NCT00174707,NCT01137994,NCT02776917,NCT02455141,NCT00075270,NCT00356811,NCT01220128,NCT00201435,NCT01779050,NCT01205217,NCT02307227,NCT05244993,NCT00110695,NCT00246571,NCT00367471,NCT00272987,NCT00709761,NCT00046527,NCT03396445,NCT00191672,NCT05067530,NCT00048893,NCT00524303,NCT00849472,NCT00174434,NCT01026116,NCT02051751,NCT00251095,NCT00353717,NCT00194753,NCT01953445,NCT00111787,NCT02622074,NCT00281658,NCT00388076,NCT00046514,NCT00448305,NCT03705429,NCT00121992,NCT01953536,NCT03678883,NCT00550771,NCT00429299,NCT00553358,NCT02162719,NCT04895358,NCT00373256,NCT01271725,NCT01138046,NCT03036488,NCT03272477,NCT03742102
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
NCT01229930,NCT05179239,NCT02446652,NCT04973904,NCT00002949,NCT00003209,NCT00003624,NCT00626561,NCT00057928,NCT00003078,NCT00823186,NCT01566240,NCT00138151,NCT00340184,NCT01756170,NCT00462397,NCT03912415,NCT00997009,NCT04551950,NCT00276796,NCT04016142,NCT04864782,NCT01667211,NCT04731038,NCT01405235,NCT02467907,NCT03635567,NCT02039791,NCT04974944,NCT03912402,NCT01755845,NCT01487226,NCT00003377,NCT04238988,NCT04884906,NCT03534713,NCT04982237,NCT05247619,NCT01594099,NCT04341883,NCT04799639,NCT02432365,NCT04150575,NCT03852979,NCT03367871,NCT05367206,NCT02422563,NCT00023660,NCT04868708,NCT00003065,NCT04806945,NCT00003379,NCT02036164,NCT00980954
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT00085358,NCT00023907,NCT00005046,NCT01821859,NCT01447706,NCT00652119,NCT01091428,NCT00373217,NCT00003064,NCT03126812,NCT00702299,NCT00483782,NCT00017303,NCT00003624,NCT00003880,NCT00079430,NCT00003120,NCT00993655,NCT00008138,NCT00031954,NCT01493505,NCT00003378,NCT00003998,NCT00825201,NCT00002894,NCT00625092,NCT00838656,NCT00003322,NCT00550784,NCT00002717,NCT00002734,NCT00005026,NCT02020707,NCT00028743,NCT00003896,NCT01083537,NCT00091377,NCT00003944,NCT00003160,NCT02272790,NCT00466960,NCT00672295,NCT01402271,NCT00408070,NCT00004934,NCT00491855,NCT02834975,NCT00075712,NCT00331422,NCT00084448,NCT01649336,NCT00003385,NCT02050009
|
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT00974818,NCT00022191,NCT00005644,NCT00003930,NCT00024349,NCT01094964,NCT01675219,NCT01149174,NCT03058757,NCT00003376,NCT02106572,NCT00045630,NCT00003342,NCT00002917,NCT00981656,NCT00003642,NCT00318643,NCT02307487,NCT00006111,NCT01920269,NCT00933374,NCT00003133,NCT00310011,NCT00002949,NCT02070120,NCT02948543,NCT02302807,NCT00003105,NCT02982395,NCT04602117,NCT00042887,NCT00585689,NCT00192049,NCT04060459,NCT03664869,NCT05024734,NCT00028860,NCT00055601,NCT00583349,NCT00268450,NCT02316171,NCT00022633,NCT00006118,NCT05328336,NCT00136175,NCT00003175,NCT00003701,NCT00023842,NCT00002490,NCT01442519
|
Pleural mesotheliomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26 |
MTOR
NCT00075699,NCT02798536,NCT00024271,NCT00030459 |
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MTOR
NCT02419495,NCT00001383,NCT00083109,NCT05092373 |
Intrahepatic cholangiocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.10 |
NCT02392637,NCT03579771,NCT04961970,NCT03771846,NCT04175912
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT00088530,NCT03169790,NCT00038545,NCT03013218,NCT01555853
|
Squamous cell carcinoma of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A.0 |
NCT03323463,NCT04718415,NCT03829722,NCT05108870,NCT04572100
|
ovarian cystadenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.Y |
NCT00079430,NCT00002913,NCT02050009,NCT00085358,NCT00466960
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
NCT00531687,NCT00072215,NCT00104676,NCT00231582,NCT00004077
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
GMNN,TSHR,CA2
NCT00687687,NCT00954174 |
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
TUBB6,ITGAV,GMNN,PMP22,LMNA
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
THPO,SLCO1B1,GMNN,TSHR,SLCO1B3
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
SLCO1B1,RAB9A,GMNN,SMN1,THRB
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
SLCO1B1,SLCO1B3
NCT04278092,NCT01612351,NCT01852292,NCT03855384,NCT03723967,NCT02369458,NCT04428151,NCT04831320,NCT00513383,NCT00736944,NCT02047201,NCT01233843,NCT01732640,NCT02270814,NCT03169764,NCT02124707,NCT05283226,NCT05054439,NCT01154920,NCT05189184,NCT03830385,NCT04843098,NCT05294900,NCT04164238,NCT04807140,NCT01177956,NCT00274937,NCT02573493,NCT04826679,NCT05459129,NCT00971932,NCT01086826,NCT04282109,NCT00002774,NCT03340896,NCT04882462,NCT05272696,NCT05446467,NCT02551159,NCT04854499,NCT02268695,NCT00999700,NCT00139269 |
Malignant neoplasms of nasopharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
NCT01694576,NCT00677118,NCT01712919,NCT03574324,NCT03175939,NCT03604965,NCT00747799,NCT03306121,NCT03047265,NCT01528618,NCT00201396,NCT04834206,NCT02016417,NCT05433597,NCT04766359,NCT03668730,NCT03020329,NCT04282070,NCT04015661,NCT00816816,NCT01534585,NCT04223024,NCT04004871,NCT01797900,NCT00816855,NCT00188877,NCT01245959,NCT04850235,NCT01536223,NCT02012062,NCT02500940,NCT00817583,NCT00379262,NCT02434614,NCT03503136,NCT02250599,NCT02590133,NCT04437329,NCT00592501,NCT00697905
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
MTOR
NCT01352689,NCT01246193,NCT01340131 |
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
NCT04502641,NCT00508664,NCT01312350,NCT01249443
|
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
NCT00014573,NCT00031577,NCT00002814,NCT01498783
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
SLCO1B1,SLCO1B3
NCT00521781,NCT04221828 |
LeukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60-2B33 |
NCT00003003,NCT00003294,NCT00003230,NCT00003402
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
NCT03800693,NCT02319018,NCT01434069,NCT04755543
|
Large cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.3 |
NCT00955305,NCT00596830,NCT03345810,NCT02186847
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
SLCO1B1,SLCO1B3
NCT02969473,NCT02395705 |
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
SLCO1B1,GMNN,TSHR,SLCO1B3
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
GMNN,SMN1,LMNA,NPC1
|
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT03853707,NCT03554044,NCT04001829,NCT02672475,NCT01091428,NCT02436993,NCT01263145,NCT02593175,NCT00542451,NCT00520975,NCT01935492,NCT04249167,NCT02187991,NCT04266249,NCT05233696,NCT02883062,NCT03606967,NCT05177796,NCT04862585,NCT02689427,NCT01463072,NCT01275677,NCT01750073,NCT03725436,NCT03101748,NCT01200992,NCT02419495,NCT02654119,NCT04081389,NCT04216472,NCT00785291,NCT03179904,NCT05422794,NCT05092373,NCT02474173,NCT02603679,NCT01238133,NCT02632071,NCT03201861
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT00193219,NCT00499369,NCT01205022,NCT04120701,NCT05174169,NCT01383343,NCT00235898,NCT05179889,NCT00646607,NCT02041481,NCT04303429,NCT00003873,NCT00004931,NCT04832776,NCT01270438,NCT04259944,NCT00025337,NCT02138617,NCT00309530,NCT01347645,NCT03641976,NCT03426904,NCT00079274,NCT02510118,NCT03883802,NCT00070122,NCT00309543,NCT04488159,NCT02967289,NCT00003835,NCT00337389,NCT01111604,NCT01198548,NCT00942266,NCT00101894,NCT05062889,NCT04003792,NCT01238965
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
MTOR
NCT00513786,NCT05489848,NCT02744898,NCT03189446,NCT00052312,NCT00334321,NCT00411138,NCT04527900,NCT05092373,NCT03932409,NCT00883116,NCT00016341,NCT00003691,NCT01367002,NCT04652076,NCT05201547,NCT00373620,NCT00879359,NCT00002949,NCT02730416,NCT00003624,NCT01244789,NCT03935256,NCT02476955,NCT00006027,NCT00022620,NCT01770171,NCT02630823,NCT00515073,NCT00006377,NCT03503786,NCT05481645,NCT03603184,NCT00003127,NCT04159155 |
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT04919226,NCT01489566,NCT00003558,NCT03387592,NCT04325425,NCT00001569,NCT03136055,NCT01858025,NCT00873119,NCT01843452,NCT00953394,NCT01253681,NCT00936702,NCT05015621,NCT00731861,NCT02172976,NCT03164382,NCT02820857,NCT01524094,NCT00193531,NCT02215447,NCT00003943,NCT00737243,NCT03168607,NCT02246127,NCT01593306,NCT00894569,NCT03092895,NCT04705519,NCT00002507,NCT03837977,NCT00022178
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
CA2,MTOR
NCT00467012,NCT01204437,NCT00289263,NCT00003680,NCT00912639,NCT00311636,NCT00336791,NCT00004092,NCT00436566,NCT00055679,NCT00915603,NCT00960960,NCT00378313,NCT00039546,NCT00006256,NCT00028873,NCT01314833,NCT03002103,NCT00052351,NCT00006459,NCT02365805,NCT00503906,NCT00193011,NCT00499083,NCT00561119,NCT04213898,NCT01003158,NCT03125902,NCT00003577,NCT00448591,NCT01008150,NCT04148911,NCT01881230,NCT00499525,NCT00002627,NCT00002662,NCT00872625,NCT00668616,NCT00025688,NCT00625898,NCT00536939,NCT02400567,NCT03057600,NCT00070278,NCT00919880,NCT00014222,NCT00003086,NCT00128856,NCT00194792,NCT00136539,NCT00005581,NCT00001383,NCT00331097,NCT00148681,NCT00533936,NCT00009763,NCT00950300,NCT00002628,NCT00003013,NCT02846428,NCT00635050,NCT03805399,NCT00589238,NCT00404404,NCT00002826,NCT00152191,NCT00002498,NCT00031876,NCT01216111,NCT00951665,NCT01818063,NCT00733408,NCT00607438,NCT02132949,NCT00001498,NCT00003088,NCT00580333,NCT00053911,NCT03888677,NCT00254592,NCT00513292,NCT03175666,NCT00915018,NCT00054028,NCT00124111,NCT03872791,NCT00929591,NCT05390710,NCT00003612,NCT00003440,NCT00688740,NCT02742051,NCT00394251,NCT00559845,NCT05491694,NCT00196872,NCT00041119,NCT00002696,NCT00093795,NCT02393833,NCT00574587,NCT00033683,NCT00724386,NCT00015886,NCT04085276,NCT00629278,NCT00028990,NCT00038402,NCT00129389,NCT00016406,NCT00017095,NCT00003893,NCT02897700,NCT00003012,NCT04770272,NCT00546156,NCT00433420,NCT04177108,NCT00096668,NCT00002870,NCT02897050,NCT00622466,NCT00717340,NCT00532285,NCT00532857,NCT00479674,NCT00320541,NCT00274456,NCT00087178,NCT01937507,NCT00795899,NCT00777673,NCT00511459,NCT01042379,NCT00486668,NCT00331630,NCT02681003,NCT00003927,NCT00002679,NCT03197935,NCT00600340,NCT00542191,NCT00434356,NCT03387085,NCT00295893,NCT00002581,NCT00129922,NCT00003392,NCT02115152,NCT00934895,NCT00616967,NCT00567554,NCT02413320,NCT00191854,NCT00003992,NCT01855828,NCT00301925,NCT00002837,NCT00006108,NCT00618657,NCT00010075,NCT00525759,NCT00107094,NCT00093145,NCT00050167,NCT00009997,NCT00773695,NCT00002772,NCT00609791,NCT00654836,NCT00070564,NCT00431080,NCT01593020,NCT01985841,NCT00475670,NCT00154882,NCT00007904,NCT00003050,NCT00002953,NCT00675259,NCT01966471,NCT04584112,NCT02450058,NCT01642771,NCT04138719,NCT00544232,NCT00503750,NCT04958785,NCT00146562,NCT00110084,NCT00003035,NCT02225652,NCT00002784,NCT00193206,NCT00002579,NCT00707707,NCT00629499,NCT00679029,NCT05227664,NCT02115204,NCT00072319,NCT00756470,NCT00499603,NCT00004067,NCT00005635,NCT00002580,NCT02299999,NCT00691379,NCT00930930,NCT00846027,NCT00591851,NCT05192798,NCT00618826,NCT00005649,NCT00442260,NCT01985724,NCT00068757,NCT00256243,NCT00047099,NCT00876395,NCT00748553,NCT02315196,NCT04129996,NCT04031703,NCT00397761,NCT00316199,NCT00392392,NCT01031030,NCT00004125,NCT00002937,NCT01358877,NCT03554109,NCT00723125,NCT00691912,NCT00236899,NCT00615602,NCT00096343,NCT00140140,NCT00194779,NCT00662129,NCT00963729,NCT00776724,NCT00803556,NCT00002582,NCT00002755,NCT00637897,NCT00768859,NCT00370552,NCT00455533,NCT00482391,NCT00807859,NCT00887575,NCT00146549,NCT00022230,NCT01222052,NCT00334802,NCT00915369,NCT00152178,NCT00900627,NCT00645177,NCT01036087,NCT00322400,NCT00820170,NCT00456846,NCT01009983,NCT00003042,NCT00820547,NCT00012311,NCT02995772,NCT00971945,NCT00356681,NCT04296175,NCT00004174,NCT02980965,NCT00856492,NCT00251472,NCT00001384,NCT00054587,NCT00983424,NCT00309569,NCT00630032,NCT00667251,NCT00407888,NCT00445458,NCT00002542,NCT00006120,NCT00301730,NCT01270373,NCT00788931,NCT00036868,NCT00003877,NCT00309478,NCT00680758,NCT01231802,NCT00004013,NCT00006110,NCT00003972,NCT00426556,NCT00403130,NCT00789581,NCT00003539,NCT00944047,NCT00019812,NCT00476827,NCT04127019,NCT00394082,NCT00479856,NCT00041470 |
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT00166465,NCT01383343,NCT00851045,NCT03069950,NCT03300609,NCT01277406,NCT00387387,NCT00034190,NCT00003835,NCT00003873,NCT04094688,NCT00967616,NCT02071069,NCT02413853,NCT01270438,NCT00096278,NCT01862003,NCT00079274,NCT00499850,NCT00707889,NCT02508077,NCT04068103,NCT03050814,NCT01605344,NCT00025337,NCT00070122,NCT01704703,NCT00507091,NCT02355379,NCT00942266
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
MTOR,CA2,ITGAV
|
Skin cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30-2C37 |
NCT00003549,NCT03167164,NCT02054884
|
Hereditary breast and ovarian cancer syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C65 |
NCT00535119,NCT02978495,NCT05485766
|
Malignant mixed epithelial mesenchymal tumour of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D.0 |
NCT02107937,NCT02822157,NCT01249443
|
Thymic carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH6AK2 |
NCT03694002,NCT00818090,NCT00010257
|
Polyneuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
NCT00979082,NCT02590367,NCT03492047
|
Mixed tumour, malignant, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0V86 |
NCT04825938,NCT01969578,NCT05000892
|
Gastrointestinal stromal tumourDisease Category: X.Extension CodesDisease ICD-11 Code: XH9HQ1 |
NCT02574663,NCT03944304,NCT02607332
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
SLCO1B1,SLCO1B3,CA2
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
THPO,THRB,CA2
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NCT01704287,NCT00084214,NCT00970996,NCT02300935,NCT01009515,NCT01039844,NCT00864253,NCT01107665,NCT01200342,NCT00483301,NCT00462423,NCT01676649,NCT00288041,NCT00434252,NCT03167177,NCT01666418,NCT00796991,NCT01006252,NCT00779714,NCT02617849,NCT02023710,NCT00522834,NCT01827111,NCT04979585,NCT00255762,NCT01174238,NCT00329641,NCT00093119,NCT00111007
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
SLCO1B1,SLCO1B3
NCT03193918,NCT02449655,NCT02545504,NCT03959293,NCT04675983,NCT02625610,NCT02494583,NCT04510064,NCT05268510,NCT03281369,NCT00183911,NCT02625623,NCT02615730,NCT04604132,NCT03990103,NCT04077255,NCT01641783,NCT01336062,NCT04209686,NCT02448329,NCT04572542,NCT04908566,NCT01567618,NCT04190745,NCT04523818 |
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
MTOR
NCT00003717,NCT00024414,NCT00030654,NCT00038246,NCT00005048,NCT00004054,NCT00003394,NCT00003614,NCT00005847,NCT00933426,NCT00084565,NCT00016913,NCT04148885,NCT00028769,NCT00049257,NCT02911350,NCT00038168,NCT00193193,NCT00284752,NCT01558492,NCT00005028,NCT00003084,NCT00003622,NCT00151060,NCT00009750 |
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
ITGAV
NCT02830139,NCT01326000,NCT00176774,NCT00884767,NCT00478946,NCT01263171,NCT01478594,NCT00209625,NCT00023751,NCT02244632,NCT01736904,NCT00016133,NCT00005586,NCT00024401,NCT00064181,NCT01077739,NCT00055822,NCT00265850,NCT00349336,NCT02291289,NCT00280176,NCT00098982,NCT00008281,NCT00003543,NCT00296608,NCT00831181,NCT00070213,NCT00385021,NCT00026364,NCT02494973,NCT00423696,NCT02375672,NCT00003260,NCT01417494,NCT04337879,NCT00212589,NCT00002893,NCT02515734,NCT00640081,NCT05081687,NCT01515787,NCT00006366,NCT00020917,NCT00002525,NCT05193292,NCT00006103,NCT00003594,NCT00940303,NCT05239741,NCT00065117,NCT01193452,NCT00797485,NCT00062426,NCT01836653,NCT00002551,NCT00321828,NCT01150045,NCT00004252,NCT00786643,NCT00427570,NCT01730586,NCT02614534,NCT00003287,NCT00749450,NCT00003422,NCT01276379,NCT02376452,NCT02885753,NCT00110721,NCT00958737,NCT01286818,NCT01183780,NCT00642577,NCT00023868,NCT00005050,NCT00671372,NCT00026273,NCT02384850,NCT03487939,NCT02103062,NCT01047293,NCT00016198,NCT00628810,NCT00303771,NCT00182715,NCT00721916,NCT00862784,NCT01068132,NCT00988897,NCT00813137,NCT00720512,NCT00335816,NCT00002593,NCT02246049,NCT00085163,NCT01227707,NCT00003254,NCT01418222,NCT00003063,NCT00111761,NCT02141295,NCT00002570,NCT00081289,NCT01383707,NCT01289821,NCT00091312,NCT00354978,NCT00006468,NCT00049101,NCT05253651,NCT01167725,NCT00025142,NCT00098787,NCT01374425,NCT00284258,NCT00004102,NCT00046995,NCT00274872,NCT00002523,NCT00004005,NCT01133990,NCT00537823,NCT00016978,NCT00278889,NCT01490866,NCT00006115,NCT01652482,NCT01205711,NCT00143403,NCT00469443,NCT00323011,NCT00647530,NCT00559741,NCT00020501,NCT01338558,NCT00039208,NCT00556413,NCT00378716,NCT01226719,NCT02842580,NCT01279681,NCT00069108,NCT00006015,NCT00625573,NCT00080951,NCT01375816,NCT01679327,NCT00719797,NCT00839111,NCT00551213,NCT00008060,NCT01529164,NCT02124148,NCT00069121,NCT00066846,NCT00612586,NCT00286000,NCT00577109,NCT01718873,NCT01815359,NCT00199797,NCT00009737,NCT01802645,NCT01479465,NCT00866944,NCT00427310,NCT00002828,NCT00973609,NCT02415699,NCT00271011,NCT00021281,NCT00072553,NCT01765582,NCT00262808,NCT01442935,NCT00002793,NCT00006786,NCT00384176,NCT00541112,NCT00066274,NCT00069095,NCT00467142,NCT00719199,NCT00004885,NCT00112918,NCT00016952,NCT00021398,NCT00118261,NCT03169777,NCT00889343,NCT00265811,NCT00613080,NCT01622543,NCT00609622,NCT00004150,NCT00002692,NCT00497497,NCT02826837,NCT05035381,NCT00126256,NCT01628211,NCT00291785,NCT00006479,NCT00873275,NCT01465451,NCT00268333,NCT00027833,NCT00202787,NCT00501410,NCT00388700,NCT00070434,NCT00001428,NCT00454116,NCT00002896,NCT00077233,NCT00778102,NCT00209703,NCT02574663,NCT00615056,NCT00005979,NCT00002716,NCT00336960,NCT01442649,NCT01271166,NCT00952029,NCT00571740,NCT00755118,NCT00058474,NCT00449137,NCT00003001,NCT00003446,NCT00268398,NCT00061815,NCT00544011,NCT00006037,NCT00202774,NCT00541125,NCT00075595,NCT00425152 |
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT02481635,NCT05193604,NCT00417976,NCT04707118,NCT04589234,NCT01905150,NCT00112658,NCT03278015,NCT02283372,NCT04723030,NCT01836432,NCT02767557,NCT03941093,NCT02672917,NCT02340117,NCT03086369,NCT03344172,NCT05251038,NCT01494506,NCT00003029,NCT01827553,NCT02351219,NCT02399137,NCT03329248,NCT02210559,NCT02919787,NCT02827201,NCT03435289,NCT02514031,NCT03336216,NCT00276744,NCT00602602,NCT01454180,NCT03586869,NCT02559674,NCT02588443,NCT00003049,NCT03316599,NCT02128100,NCT03520790,NCT00967291,NCT01661088,NCT03387098,NCT02021422,NCT02873598,NCT01296763,NCT04897854,NCT00601627,NCT00463840,NCT04228601,NCT03760614,NCT00005870,NCT02207465,NCT03714555,NCT01858883,NCT00112697,NCT01632306,NCT03487016,NCT03636308,NCT02651727,NCT04431258,NCT03412799,NCT05360732,NCT02608229,NCT03252808,NCT00003591,NCT01489865,NCT04674956,NCT03136406,NCT03777462,NCT05462496,NCT03649321,NCT04054362,NCT02676349,NCT04089150,NCT01964534,NCT03989310,NCT02028806,NCT05047991,NCT04683939,NCT04643405,NCT04104672,NCT03519308,NCT02705196,NCT02241551,NCT02050178,NCT03641183,NCT01446458,NCT03417921,NCT02574663,NCT03415802,NCT04581876,NCT01834235,NCT00323583,NCT00398086,NCT00844649,NCT00960284,NCT00003018,NCT03563248,NCT01652976,NCT00003216,NCT03504423,NCT00262951,NCT02930902,NCT04807972,NCT04390399,NCT00251355,NCT00033735,NCT03825328,NCT03797443,NCT02106884,NCT02005315,NCT00416507,NCT01560949,NCT00024427,NCT04592861,NCT04158635,NCT03815461,NCT03991962,NCT02391662,NCT05466799,NCT01010945,NCT03699319,NCT00058201,NCT00609765,NCT04814485,NCT02405585,NCT03443492,NCT01523457,NCT03600623,NCT01063192,NCT02355119,NCT03042780,NCT00691054,NCT01647828,NCT01088815,NCT02311439,NCT04498689,NCT03693677,NCT03257033,NCT00111904,NCT00059826,NCT01461915,NCT00024375,NCT01934634,NCT00026130,NCT00005871,NCT01485744,NCT05497778,NCT02975141,NCT04594772,NCT01754623,NCT01470417,NCT01839487,NCT03861702,NCT03563144,NCT00089024,NCT04617067,NCT05185869,NCT02352337,NCT04858009,NCT03850769,NCT03585062,NCT01867892,NCT01893801,NCT01688336,NCT04371224,NCT00786006,NCT04769414,NCT02109341,NCT02717091,NCT04683315,NCT02551991,NCT04241276,NCT02581215,NCT00882973,NCT02506842,NCT00275119,NCT05298020,NCT04753879,NCT03899636,NCT02581501,NCT02539537,NCT00002955,NCT01473303,NCT04084496,NCT04447092,NCT01591733,NCT02382263,NCT02124317,NCT00068575,NCT01822756,NCT01730222,NCT01888978,NCT01488552,NCT03167112,NCT00424827,NCT04672005,NCT05168527,NCT01621243,NCT02109445,NCT03484299,NCT00660270,NCT03502343,NCT04902261,NCT02506803,NCT03883919,NCT02358161,NCT00002689,NCT03885219,NCT04161755,NCT02923921,NCT00436267,NCT02570711,NCT02272738,NCT01693276,NCT05241249,NCT05065801,NCT00010062,NCT00004003,NCT01978184,NCT00049348,NCT02135822,NCT02043730,NCT04247126,NCT01821729,NCT01851174,NCT00045747,NCT05218889,NCT02155088,NCT01992705,NCT05346146,NCT04324307,NCT02047500,NCT03721744,NCT00303758,NCT02138383
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
NCT03778593,NCT03110510,NCT01572324,NCT01530503,NCT04722133,NCT00090025,NCT03785873,NCT04492033,NCT04005339,NCT04692051,NCT02632305,NCT04004234,NCT01494363,NCT04217954,NCT03830606,NCT01127555,NCT04027764,NCT05052099,NCT03524508,NCT05170438,NCT03291899
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT03577704,NCT00399126,NCT01419548,NCT03326947,NCT00653939,NCT00413322,NCT00486954,NCT01566435,NCT03907475,NCT00193596,NCT00005791,NCT01455532,NCT03503604,NCT01297452,NCT01159418,NCT00042874,NCT00793897,NCT04594005,NCT01099358,NCT01248949,NCT00350025,NCT05214976,NCT00881101,NCT05017012,NCT00556088,NCT01411410,NCT00458315,NCT04185883,NCT00520000,NCT02817113,NCT03250832,NCT00811993,NCT00088114,NCT02593708,NCT04449549,NCT03834948,NCT00360360,NCT03309150,NCT03588039,NCT01862328,NCT00891605,NCT01868022,NCT02630264,NCT04761601,NCT04778839,NCT03981796,NCT05344742,NCT00809133,NCT01285466,NCT00848718,NCT01362374,NCT01017640,NCT01206465,NCT00043121,NCT04794699,NCT02730481,NCT01031212,NCT02648711,NCT02711137,NCT01593228,NCT03085914,NCT00016874,NCT00001387,NCT00020488,NCT02715531,NCT01548924,NCT01472016,NCT00287937,NCT01281176,NCT04541108,NCT01047007,NCT05262335,NCT02317874,NCT01494688,NCT02482441,NCT00607048,NCT00005068,NCT00003242,NCT04151277,NCT02122770,NCT02720068,NCT00454649,NCT00768469,NCT03430882,NCT00004913,NCT00954512,NCT02723955,NCT03595059,NCT01946074,NCT01491204,NCT04176952,NCT04675528,NCT03154294,NCT02341456,NCT00261703,NCT04420884,NCT00003004,NCT02051751,NCT00003710,NCT05381909,NCT00995293,NCT03564691,NCT02430311,NCT00007878,NCT01938846,NCT01617928,NCT01515306,NCT01525602,NCT04607421,NCT00006257,NCT00289445,NCT00042861,NCT02588105,NCT04802980,NCT01994031,NCT01930292,NCT03057366,NCT01240655,NCT00838370,NCT04047862,NCT01992341,NCT02937272,NCT03421353,NCT00009828,NCT00006018,NCT00003092,NCT00009802,NCT03693612,NCT02607202,NCT01968915,NCT02057380,NCT01967043,NCT00100139,NCT04393298,NCT00004173,NCT00002587,NCT00005078,NCT00003555,NCT04742036,NCT05322720,NCT04143711,NCT03600090,NCT00004059,NCT01634555,NCT00001442,NCT00502567,NCT00024141,NCT02379416,NCT00002939,NCT00021073,NCT00448136,NCT01293630,NCT00496028,NCT00003130,NCT02979392,NCT00080418,NCT00215501,NCT00357149,NCT04180384,NCT01930552,NCT00042809,NCT02762981,NCT02134067,NCT00095914,NCT00004863,NCT03894540,NCT02884128,NCT01522989,NCT00030368,NCT00044785,NCT00003742,NCT00004979,NCT00511849,NCT04336098,NCT02648425,NCT03537690,NCT03892018,NCT00307255,NCT00246103,NCT03928314,NCT03486314,NCT00054548,NCT00005819,NCT03330106,NCT00009932,NCT02597036,NCT00087217,NCT00003899,NCT00024310,NCT04035473,NCT00004242,NCT00046423,NCT00610948,NCT00402545,NCT04046016,NCT03918278,NCT03601897,NCT00028587,NCT04481009,NCT00422682,NCT02283489,NCT02794571,NCT00080990,NCT04999969
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT01702714,NCT01993810,NCT00752115,NCT00148395,NCT01769391,NCT01820754,NCT02073968,NCT00642759,NCT00174356,NCT00787852,NCT00654758,NCT00807612,NCT00730925,NCT00449657,NCT00687817,NCT00006929,NCT00753909,NCT02220894,NCT01171170,NCT00061646,NCT00948675,NCT00702572,NCT02041533,NCT00702975,NCT00874107,NCT02117024,NCT00735696,NCT00806286,NCT02405910,NCT02204345,NCT00861627,NCT00832494,NCT00874848,NCT01165216,NCT00087802,NCT02252796,NCT00666692,NCT00960297,NCT02259621,NCT00602797,NCT01158144,NCT00198354,NCT00042302,NCT01024062,NCT02382406,NCT01090830,NCT01196234,NCT00828841,NCT00259675,NCT00050960,NCT00915005,NCT02142738,NCT02039674,NCT00035152,NCT00094835,NCT02289456,NCT02420314,NCT02172846,NCT01702844,NCT00680940,NCT01236716,NCT01199055,NCT00252798,NCT00097227,NCT00974584,NCT02250326,NCT02264990,NCT01560104,NCT02364999,NCT03169738,NCT00850577,NCT00866528,NCT00294762,NCT00088088,NCT00071188,NCT02226757,NCT00800202,NCT00723957,NCT00662597,NCT02419495,NCT00178256,NCT02182232,NCT01303926,NCT00049790,NCT00708812,NCT00762034,NCT00152477,NCT00070629,NCT00085839,NCT02392507,NCT02412371,NCT01649947,NCT01820325,NCT00991796,NCT01249443,NCT00903942,NCT00918203,NCT00112294,NCT02453282,NCT01519804,NCT01268059,NCT00199758,NCT00168883,NCT00437749,NCT02367794,NCT00662311,NCT00113516,NCT00473889,NCT00161278,NCT01364012,NCT01383148,NCT00603538,NCT00527735,NCT00273507,NCT00073723,NCT00198367,NCT00191256,NCT00034541,NCT01225302,NCT00970580,NCT00933803,NCT02403895,NCT01011075,NCT00434135,NCT02477826,NCT01493843,NCT01783197,NCT01234038,NCT00986674,NCT00966914,NCT00434226,NCT00093756,NCT03574649,NCT00198432,NCT00976677,NCT00254891,NCT01310244,NCT01620190,NCT01822496,NCT00686322,NCT00578149,NCT00480831,NCT02322281,NCT00268970,NCT00313768,NCT02366143,NCT00005065,NCT02016209,NCT00558636,NCT00343291,NCT00147537,NCT00347412,NCT00280787,NCT02276560,NCT01872403,NCT01757288,NCT01507428,NCT00540514,NCT00322452,NCT02319889,NCT00088556,NCT01763645,NCT00832819,NCT01160601,NCT00539331,NCT02106546,NCT00318136,NCT01366131,NCT01413750,NCT01179269,NCT00298415,NCT01763671,NCT01496742,NCT01100931,NCT00269828,NCT01980472,NCT00716534,NCT01454102,NCT00655850,NCT00686959,NCT02083679,NCT02064491,NCT01836679,NCT00369070,NCT00768131,NCT01069328,NCT01527864,NCT01326767,NCT00300885,NCT01966003,NCT00001450,NCT00291850,NCT00614484,NCT00583830,NCT00481078,NCT01711697,NCT00460317,NCT00563784,NCT00034164,NCT00576225,NCT01912625,NCT00508625,NCT00001499
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
CA2
NCT01297803,NCT02016898,NCT02805257,NCT02385370,NCT01440751,NCT02805257,NCT00661583,NCT00626782,NCT00472810,NCT03924544,NCT00000122,NCT00893490,NCT02901236,NCT03766425,NCT02767219,NCT00666237,NCT00346489,NCT01263834,NCT00449098 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
ITGAV
NCT00103974 |
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN1,SMN2
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
CA2
NCT00055133 |
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR,THRB
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
MTOR
NCT02311907 |
Metastatic lung neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D70 |
NCT03678883,NCT00128037
|
Penile cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C81 |
NCT00512096,NCT04475016
|
Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30 |
NCT01555853,NCT01929941
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
NCT00117572,NCT00117572
|
Carcinoma, undifferentiated, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1YY4 |
NCT00989651,NCT00108745
|
Neoplasms of unknown behaviour of larynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F91.0 |
NCT00117572,NCT00599131
|
strictureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB80.Z-LB15.1 |
NCT01868984,NCT02040454
|
Chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
NCT03064126,NCT00518284
|
Neuroendocrine neoplasms of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.1 |
NCT03736720,NCT03042780
|
Soft tissue disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB56 |
NCT03524898,NCT05189483
|
ThymomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
NCT00010257,NCT00818090
|
Diseases of the digestive system, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
NCT00526110,NCT00208936
|
Neoplasms of unknown behaviour of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F90.0 |
NCT03484195,NCT02777437
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
SLCO1B1,SLCO1B3
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
GMNN,GMNN
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
TUBB3,SLCO1B3
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
NPC1,CA2
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
TUBB6,THPO
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
GMNN,TUBB3
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT00003624,NCT01654146,NCT00034151,NCT01644825,NCT02159820,NCT00023907,NCT00004934,NCT02476955,NCT00003733,NCT00003322,NCT01778803,NCT00672295,NCT00391118,NCT02389985,NCT02718417,NCT00550784,NCT02834975,NCT01954355,NCT01653912,NCT02312661,NCT00189371,NCT01739218,NCT00373217,NCT01838538,NCT02121990,NCT03025477,NCT02157870,NCT01146795,NCT00003120,NCT03126812,NCT03467178,NCT02092363,NCT02483104,NCT03197584,NCT00314678,NCT00993655,NCT00479817,NCT04729387,NCT02948075,NCT00231075,NCT00193297,NCT04374630,NCT02766582,NCT03699449,NCT03393507,NCT00517621,NCT00075712,NCT00652119,NCT00003064,NCT00228319,NCT00158379,NCT00005051,NCT00003214,NCT04931342,NCT00390611,NCT03038100,NCT00129727,NCT00702299,NCT04908787,NCT02125513,NCT00226915,NCT05316376,NCT00189566,NCT03806049,NCT00002717,NCT00002568,NCT03029611,NCT04679064,NCT00838656,NCT00170664,NCT00002894,NCT04000295,NCT02440425,NCT03942068,NCT00331422,NCT00006454,NCT00084448,NCT02520154,NCT03117933,NCT01493505,NCT01649336,NCT00750386,NCT03940196,NCT00840450,NCT00003896,NCT00003413,NCT00005026,NCT03287271,NCT02004093,NCT00772798,NCT00585052,NCT00003944,NCT04729608,NCT03989336,NCT05145569,NCT01253681,NCT00466986,NCT05255471,NCT03818282,NCT03740165,NCT04608409,NCT03410784,NCT00408070,NCT00001383,NCT03398655,NCT03394885,NCT02545010,NCT04261465,NCT04072263,NCT03763123,NCT00102622,NCT02470585,NCT00003385,NCT05044871,NCT04337632,NCT03635489,NCT03393884,NCT01802749,NCT00008138,NCT00002928,NCT01083537,NCT00401674,NCT01332656,NCT00002819,NCT01204749,NCT01081951,NCT00657878,NCT00520013,NCT00002734,NCT00976911,NCT04661696,NCT04815408,NCT01402271,NCT00937560,NCT02012192,NCT00825201,NCT01357161,NCT00003160,NCT00660842,NCT00005612,NCT00490711,NCT00483782,NCT03639246,NCT00886717,NCT00945191,NCT00889382,NCT00003880,NCT00091377,NCT00610714,NCT03056833,NCT04921527,NCT03776812,NCT00003644,NCT01711970,NCT00964626,NCT00017303,NCT00326456,NCT04590625,NCT04938583,NCT01219777,NCT00929162,NCT01821859,NCT03539328,NCT00003378,NCT01239732,NCT03901118,NCT00003998,NCT00003449,NCT03246074,NCT00028743,NCT01570582,NCT00738699,NCT05145218,NCT00052468,NCT00005046,NCT00189553,NCT03737643,NCT01684878,NCT00004206,NCT00003386,NCT01196741,NCT00004921,NCT00063401,NCT01447706,NCT05371301,NCT00031954,NCT02001272,NCT00011986,NCT01650376,NCT01696032,NCT01220154,NCT00003732,NCT02383251,NCT01485848
|
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT00046423,NCT00046527,NCT00781612,NCT03678883,NCT02124148,NCT00984464,NCT02158520,NCT01721746,NCT01014351,NCT00065117,NCT00289445,NCT01933061,NCT02419495,NCT00126256,NCT00374036,NCT00149201,NCT00731861,NCT00046514,NCT00048893
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT03219762,NCT04698941,NCT02769832,NCT02038647,NCT04247126,NCT05420636,NCT04213937,NCT00527735,NCT04314895,NCT00317200,NCT04056949,NCT02551432,NCT01441349,NCT04672928,NCT04210037,NCT00454324,NCT03810872,NCT02262897,NCT00617409
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
MTOR
NCT03435250,NCT00009776,NCT00001579,NCT00003402,NCT00001383,NCT00003294,NCT00003957,NCT00003956,NCT00003397,NCT03884556,NCT00004057,NCT00027937,NCT00021372,NCT00004916,NCT04856137,NCT00008021,NCT00005021 |
Malignant neoplasms of anus or anal canalDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C00 |
NCT01324141,NCT01671488,NCT01621217,NCT02369939,NCT00003596,NCT00324415,NCT02059499,NCT00068744,NCT01249443,NCT00955240,NCT00423293,NCT00025090,NCT00003652,NCT03381352,NCT02701088,NCT01941966,NCT02402842,NCT00316888
|
Carcinomas of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.0 |
NCT01970722,NCT03400306,NCT00181701,NCT03030287,NCT05092373,NCT03690739,NCT05158062,NCT05446870,NCT01847677,NCT02244502,NCT02272790,NCT02419495,NCT02107378,NCT03756818,NCT03598270,NCT01091428,NCT04602117,NCT02437812
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
NCT00384878,NCT02934464,NCT01774786,NCT00210184,NCT04342910,NCT00155883,NCT00004099,NCT01136031,NCT03675737,NCT00103103,NCT00941655,NCT00003862,NCT05171530,NCT02114359,NCT04694183,NCT04267549,NCT01889303,NCT00661167,NCT01248403,NCT00154726,NCT02890511,NCT04943653,NCT01183559,NCT04149015,NCT04155671,NCT04997837,NCT00004233,NCT05319639,NCT02845908,NCT01249443,NCT01170663,NCT00611507,NCT05204173,NCT03977220,NCT03579784,NCT00002883,NCT01641939,NCT04563975,NCT01471132,NCT00202969,NCT02451956,NCT03286244,NCT04835896,NCT01286766,NCT00142350,NCT02142322,NCT02072317,NCT01015339,NCT00002722,NCT01924533,NCT00270543,NCT05427383,NCT00976768,NCT01746771,NCT01457846,NCT00002783,NCT00209612,NCT03766607,NCT01285557,NCT04135781,NCT05400915,NCT05190445,NCT05025033,NCT00595972,NCT00992199,NCT01896531,NCT00555672,NCT04683939,NCT04308837,NCT04358341,NCT00525785,NCT02578368,NCT02038621,NCT02486601,NCT01503372,NCT01662869,NCT00003298,NCT01198392,NCT00004873,NCT00313872,NCT02442362,NCT02931890,NCT00020787,NCT00296335,NCT02697838,NCT02855788,NCT01491217,NCT01063517,NCT00374036,NCT01924819,NCT00052910,NCT00054873,NCT01042782,NCT00005060,NCT00514020,NCT03704077,NCT01839773,NCT03428425,NCT04354662,NCT05095467,NCT02229058,NCT04937738,NCT03015675,NCT03475615,NCT04781413,NCT04195828,NCT04286711,NCT03718624,NCT01739894,NCT03751761,NCT00123318,NCT01283204,NCT00711243,NCT03939962,NCT00296322,NCT04888663,NCT00188266,NCT01851941,NCT03026881,NCT00400179,NCT00343239,NCT00215514,NCT05410847,NCT04483076,NCT03801668,NCT03694522,NCT03322969,NCT04393584,NCT04258657,NCT02574663,NCT03130790,NCT02563054,NCT01224652,NCT00003172,NCT04182724,NCT05002686,NCT00447967,NCT05070598,NCT00002615,NCT00811447,NCT04379596,NCT04757363,NCT00857246,NCT03607656,NCT04001569,NCT04258644,NCT01980810,NCT03263741,NCT03606928,NCT02296671,NCT04358354,NCT01041404,NCT03067792,NCT01590719,NCT03825861,NCT00149201,NCT05052931,NCT01216644,NCT04526470,NCT04859582,NCT04602117,NCT01769508,NCT05441254,NCT04592211
|
Malignant neoplasms of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT03574779,NCT01616303,NCT00001272,NCT00069901,NCT01279291,NCT00191646,NCT01121406,NCT03314740,NCT02903004,NCT00653952,NCT00001426,NCT01608009,NCT04561817,NCT04711161,NCT00919984
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
NCT00063401,NCT03740165,NCT00001569,NCT00191646,NCT02125513,NCT00666991,NCT00189566,NCT03030287,NCT00391118,NCT00517621,NCT01279291,NCT00189371,NCT03056833,NCT03038100,NCT00352755
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
NCT00417209,NCT04289792,NCT02301143,NCT03807999,NCT01413022,NCT05083247,NCT05493995,NCT01121848,NCT02017015,NCT02024009,NCT04808687,NCT05222204,NCT00220649,NCT02810418
|
Inflammatory carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C62 |
NCT05383196,NCT01730833,NCT02199418,NCT02682693,NCT01938833,NCT02879513,NCT02125344,NCT01880385,NCT02221999,NCT02876302,NCT03515798,NCT01583426,NCT00016276,NCT00513695
|
Malignant neoplasms of fallopian tube, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74.Z |
NCT01279291,NCT00954174,NCT00063401,NCT02419495,NCT01167712,NCT05092373,NCT01970722,NCT00391118,NCT02125513,NCT03030287,NCT03776812,NCT00191646,NCT02272790
|
Carcinoma of male breastDisease Category: X.Extension CodesDisease ICD-11 Code: XH5KW8 |
NCT00861705,NCT03018080,NCT01276496,NCT00470301,NCT01288261,NCT00513695,NCT00770809,NCT02060253,NCT01281150,NCT01938833,NCT00368875,NCT00119262,NCT01493310
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
MTOR
NCT00795340,NCT00002969,NCT00276588,NCT00553462,NCT00096226,NCT00062062,NCT00533585,NCT00334763,NCT00533949,NCT00287989,NCT00063258,NCT00547443,NCT00033410,NCT00079287,NCT01862081,NCT00729612,NCT01024712,NCT00828009,NCT00004265,NCT00003812,NCT00465907,NCT00979212,NCT00005646,NCT00003317,NCT02733250,NCT01107626,NCT00004093,NCT00004924,NCT00290537,NCT00245154,NCT00003387,NCT00004159,NCT00495170,NCT04647344,NCT00005849,NCT00807573,NCT00081302,NCT00003281,NCT00003117,NCT00748163,NCT00077246,NCT00003158,NCT00003587,NCT01285609,NCT00452803,NCT00550537,NCT00616031,NCT00526890,NCT00801736,NCT00005059,NCT00025480,NCT00004011,NCT00003589,NCT02044601,NCT03348904,NCT01057342,NCT00661193,NCT00551733,NCT00459121,NCT00003235,NCT00006049,NCT00003696,NCT03322566,NCT02328105,NCT00006378,NCT00004126,NCT00004887,NCT00003159,NCT00003240,NCT00004859,NCT00278148,NCT00033696,NCT00003943,NCT00054392,NCT00003313,NCT00004055,NCT00004209,NCT00006469,NCT00028938,NCT02525653,NCT00453167,NCT00020007,NCT00004202,NCT00004253,NCT00032032,NCT00002972,NCT02513563,NCT03432598,NCT00004137,NCT00023673,NCT00006004,NCT02279732,NCT00003299,NCT00003284,NCT00077220,NCT00003881,NCT00005825,NCT00006374,NCT00003111,NCT01486602,NCT00005032,NCT00017407,NCT00011921,NCT00004160,NCT00006229,NCT00144053,NCT00055887,NCT00006012,NCT00728845,NCT00005806,NCT00062010,NCT00085501,NCT00280150,NCT00002519,NCT00025389,NCT00193362,NCT00016315,NCT00006484,NCT00193310,NCT00544648,NCT00062179,NCT00054210,NCT00039039,NCT00003089,NCT00033553,NCT00226590,NCT00043108 |
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NCT03308552,NCT00209690,NCT03881111,NCT00069953,NCT03731442,NCT02133612,NCT03087864,NCT01444547,NCT02762474,NCT02607982,NCT03328234,NCT03279237,NCT04005170,NCT00259402,NCT00002984,NCT02446574,NCT00570531,NCT02735239,NCT02023593,NCT00539617,NCT02598687,NCT00416858,NCT03490292,NCT02461043,NCT00730353,NCT00281788,NCT00209716,NCT00004233,NCT03002064,NCT02569242,NCT02861690,NCT05174156,NCT05357846,NCT04006041,NCT04540211,NCT03189719,NCT04278287,NCT03281369,NCT01704690,NCT00551759,NCT00004897,NCT02279134,NCT00002884,NCT01998347,NCT00759226,NCT03126708,NCT02570893,NCT00021320,NCT00002883,NCT00425425,NCT04821765,NCT02741856,NCT00041262,NCT04460066,NCT00047112,NCT01611857,NCT03764553,NCT00655876,NCT00003087,NCT00008047,NCT00393068,NCT02429622,NCT04879368,NCT02297217,NCT03691090,NCT02924909,NCT00006472,NCT00020787,NCT05013697,NCT00052910,NCT00107341,NCT00381706,NCT00453323,NCT00861094,NCT00003118,NCT01348217,NCT00544362,NCT00230451,NCT00154700,NCT00193882,NCT02359968,NCT00075738,NCT00002711,NCT00815308,NCT02574663,NCT00154804,NCT00054873,NCT01217060,NCT01787006,NCT00632333,NCT03910634,NCT00016900,NCT02317991,NCT03110926,NCT00193141,NCT00258323,NCT00139633,NCT00733889,NCT00160030,NCT00735345,NCT01843049,NCT00915850,NCT01843829,NCT00003326,NCT00971841,NCT04426955,NCT00066716,NCT02644863,NCT00086996,NCT00686114,NCT01249443,NCT00493025,NCT00344552,NCT00525915,NCT02273713,NCT02858206,NCT03165994,NCT01372202,NCT00006245,NCT00004257,NCT04046575,NCT01608464,NCT01034189,NCT02891083,NCT01183559,NCT00002631,NCT02389751,NCT00002897
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
MTOR
NCT00020449,NCT00033644,NCT00003008,NCT00217607,NCT00003128,NCT00003054,NCT00112489,NCT00652860,NCT03678883,NCT00003624,NCT00002993 |
Neoplasms of unknown behaviour of urinary organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F98 |
NCT00005831,NCT00734994,NCT02710734,NCT05203913,NCT04876313,NCT00478361,NCT05024773,NCT02560038,NCT04241185,NCT02311101,NCT04172675,NCT02695771
|
Actinic keratosisDisease Category: X.Extension CodesDisease ICD-11 Code: XH36H6 |
NCT03083470,NCT01354717,NCT02616601,NCT02289768,NCT02281682,NCT03037541,NCT00696488,NCT05078827,NCT00377273,NCT01525329,NCT04875026,NCT02019355
|
Melanoma of skin, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30.Z |
NCT02020707,NCT00404235,NCT02419495,NCT00976573,NCT00278122,NCT02308553,NCT00568451,NCT00081042,NCT00110019,NCT00626405,NCT02158520
|
CholangiocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7M15 |
NCT05348811,NCT03943043,NCT04683939,NCT02994251,NCT04077983,NCT02456714,NCT04480190,NCT01963325,NCT02181634,NCT03603834,NCT05024513
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
SLCO1B3,CA2
NCT04865289,NCT04269200,NCT04602117,NCT05173987,NCT02725268,NCT03517449,NCT04634877,NCT01820858,NCT03884101 |
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT02270606,NCT02887313,NCT01941641,NCT02280070,NCT03781323,NCT04215731,NCT03428529,NCT00145769,NCT01060007,NCT03152370,NCT00278694,NCT00527111,NCT00349076,NCT00321685,NCT01274962,NCT02008656,NCT01871571,NCT03161574,NCT04170530,NCT02704520,NCT00006094,NCT01269216,NCT02465593,NCT04808323,NCT05412082,NCT05201430,NCT00422864,NCT00707889,NCT01205022,NCT00611858,NCT04423965,NCT02574663,NCT05253846,NCT01111604,NCT05358704,NCT05074966,NCT01500993,NCT03259035,NCT00025337,NCT01376453,NCT00003873,NCT03548961,NCT01198548,NCT04838496,NCT04380337,NCT03443661,NCT03300544,NCT01650428,NCT03000374,NCT04009876,NCT00003799,NCT02041481,NCT00580073,NCT03975049,NCT00052559,NCT04418895,NCT03484221,NCT05378919,NCT00942266,NCT02942563,NCT03043729,NCT00235898,NCT00865189,NCT05108428,NCT01554059,NCT02688712,NCT03671252,NCT00307736,NCT03391843,NCT00807911,NCT01347645,NCT03127007,NCT00832299,NCT00101894,NCT01269229,NCT05009069,NCT03299660,NCT00303628,NCT01197664,NCT02921256,NCT01716949,NCT03085992,NCT02217020,NCT04130854,NCT02319304,NCT05111860,NCT01013805,NCT04165772,NCT01481545,NCT02167321,NCT00499369,NCT02423226,NCT01740648,NCT03921684,NCT04495088,NCT04621370,NCT05022030,NCT05024097,NCT02941562,NCT00070122,NCT01270438,NCT01238965,NCT01211210,NCT02514278,NCT00337389,NCT02340949,NCT03879109,NCT01302613
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT02784288,NCT03866993,NCT04807673,NCT04548440,NCT01752205,NCT04949256,NCT04229459,NCT03370406,NCT05213312,NCT05449483,NCT04937673,NCT03387111,NCT02033538,NCT01391572,NCT03603756,NCT04472429,NCT05319730,NCT01386385,NCT02611700,NCT04926753,NCT04943445,NCT05125055,NCT00816634,NCT04084158,NCT02976909,NCT04460352,NCT01181401,NCT04390958,NCT03957590,NCT04506138,NCT03975270,NCT00176267,NCT03292822,NCT02383966,NCT04568200,NCT02017600,NCT04839731,NCT05322499,NCT00176254,NCT01225523,NCT04138212,NCT03109158,NCT01249443,NCT01591135,NCT04929041,NCT04888403,NCT04718415,NCT05394415,NCT05342636,NCT04625543,NCT03732508,NCT02027428,NCT02677597,NCT04649476,NCT01248299,NCT05469061,NCT03116152,NCT04764227,NCT01688700,NCT02272699,NCT03946969,NCT01627379,NCT01258192,NCT02325986,NCT03783442,NCT00705016,NCT02059967,NCT02459457,NCT03430843,NCT01542931,NCT01914900,NCT01166542,NCT05007145,NCT03278626,NCT03762564,NCT02350517,NCT01822613,NCT04644250,NCT03964753,NCT04804696,NCT03748134,NCT05221658,NCT03940001,NCT04225364,NCT04063683,NCT04844385,NCT00042835,NCT02218164,NCT05281003,NCT00596830,NCT02916511,NCT03719924,NCT04767295,NCT02485548,NCT01969955,NCT04354961,NCT05312372,NCT03224221,NCT00753038,NCT01836029,NCT00998192,NCT04550260,NCT05189730,NCT00001442
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
MTOR
NCT00003907,NCT03164382,NCT00471484,NCT00238160,NCT01011010,NCT00507585,NCT00949182,NCT03092895,NCT00732836 |
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
MTOR
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
MTOR
|
Arteries/arterioles disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD52 |
MTOR
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CA2
|
Duodenal ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA63 |
CA2
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
MTOR
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
CA2
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
MTOR
|
Low bone mass disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83 |
CA2
|
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
THRB
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CA2
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
THPO
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
CA2
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
MTOR
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
MTOR
|
HydrocephalusDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D64 |
MTOR
|
LymphangioleiomyomatosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB07 |
MTOR
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA2
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
MTOR
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
THPO
|
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
THRB
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
RAB9A
|
Other specified malignant neoplasms of the ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.Y |
NCT02429700
|
Malignant trophoblastic neoplasms of placentaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C75.0 |
NCT02639650
|
Malignant neoplasms of vaginaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C71 |
NCT00002949
|
Mucinous adenocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1S75 |
NCT00068692
|
Malignant neoplasms of larynx, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C23.Z |
NCT00508664
|
Malignant neoplasm metastasis in bone or bone marrowDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E03 |
NCT03678883
|
Cervical intraepithelial neoplasiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E66 |
NCT03143491
|
Corneal scars or opacitiesDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A77 |
NCT02030990
|
Basal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C32 |
NCT03541252
|
Other specified non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92.Y |
NCT04853082
|
Verrucous carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5PM0 |
NCT01249443
|
Small cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0YB0 |
NCT02881125
|
Malignant neoplasms of nasal cavityDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C20 |
NCT00117572
|
Pleomorphic adenomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH2KC1 |
NCT00502203
|
Low grade squamous intraepithelial lesion of cervix uteriDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA15.7 |
NCT00000758
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
NCT00277043
|
Teratoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH83G5 |
NCT00104676
|
Signet ring cell carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4546 |
NCT00217737
|
Prostate hyperplasiaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA90 |
NCT03423979
|
Other specified malignant neoplasms of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A.Y |
NCT01249443
|
Relapsing-remitting multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.0 |
NCT00382629
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
NCT00003331
|
Diseases of coronary artery, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Z |
NCT00124943
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT00217737
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT00479765
|
Mesotheliomas of peritoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51.2 |
NCT05449366
|
Ependymoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1511 |
NCT01498783
|
Oesophageal obstructionDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA20.0 |
NCT04037072
|
Neoplasms of unknown behaviour of female genital organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F96 |
NCT02182245
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00003331
|
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT00002524
|
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
NCT00003350
|
Chalazion, unspecifiedDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A02.0Z |
NCT02025023
|
Glioma, malignantDisease Category: X.Extension CodesDisease ICD-11 Code: XH4RQ3 |
NCT03678883
|
Neuroendocrine tumour, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8DS0 |
NCT04602117
|
XerostomiaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA02.1 |
NCT04392622
|
Sex cord-gonadal stromal tumour, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH9G57 |
NCT01770301
|
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT01249443
|
Adrenal cortical carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KH2 |
NCT00786110
|
AnemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A00-3A9Z |
NCT00189371
|
Malignant neoplasms of other or unspecified parts of biliary tractDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
NCT05350943
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
NCT02835586
|
Type1diabetesmellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10 |
NCT01581476
|
KeratoconusDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A78.50 |
NCT04811924
|
Parathyroid carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7JQ0 |
NCT03181100
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NCT02560220
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
NCT02591030
|
Degenerative high myopiaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B76 |
NCT00999973
|
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
NCT00849264
|
Posterior blepharitisDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A02.1 |
NCT01647217
|
Malignant neoplasms of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A |
NCT03416153
|
Primary neoplasms of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
NCT00479765
|
Malignant neoplasms of appendixDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B81 |
NCT01815359
|
Malignant neoplasms of other or unspecified parts of mouthDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B66 |
NCT00933387
|
Squamous intraepithelial neoplasia, high gradeDisease Category: X.Extension CodesDisease ICD-11 Code: XH3EA2 |
NCT02059499
|
Gallbladder/bile ducts/liver structural developmental anomalyDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LB20 |
NCT02392637
|
VitreoretinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B78 |
NCT00370760
|
Malignant neoplasm metastasis in female reproductive systemDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E05 |
NCT02739529
|
Malignant neoplasms of vulvaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C70 |
NCT00014599
|
Ductal carcinoma in situ of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65.2 |
NCT02779855
|
Human immunodeficiency virus type 1Disease Category: X.Extension CodesDisease ICD-11 Code: XN8LD |
NCT01435018
|
skin carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C31.0-2E67.40 |
NCT02218164
|
Primary sclerosing cholangitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.2 |
NCT01688024
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
NCT00006276
|
Urethral strictureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC03 |
NCT00918528
|
Other specified carcinoma in situ of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65.Y |
NCT01891357
|
GliosarcomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9RC8 |
NCT04528680
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT03003546
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
NCT02311907
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
NCT02220673
|
PterygiumDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A61.1 |
NCT01115517
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
SLCO1B3
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
CA2
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
SLCO1B3
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
TSHR
|
Idiopathic pulmonary fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03.4 |
SLCO1B3
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
TSHR
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
TUBB3
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
ITGAV
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
GMNN
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
THPO
|